ADD CONDITION
Menthol
Last content change checked dailysee data sync status
- Active ingredient
- Menthol 2.7 mg/2850 mg – 5 1/85 g
- Reference brand
- Natural Honey Herb Cough Suppressant Throat Drops
- Dosage forms
- Aerosol, Foam
- Aerosol, Spray
- Chewable Gel
- Cloth
- Cream
- Emulsion
- Gel
- Gel, Dentifrice
- Granule
- Granule, for Solution
- Liniment
- Lipstick
- Liquid
- Liquid, Extended Release
- Lotion
- Lozenge
- Mouthwash
- Oil
- Ointment
- Paste
- Paste, Dentifrice
- Pastille
- Patch
- Patch, Extended Release
- Plaster
- Powder
- Salve
- Soap
- Solution
- Spray
- Stick
- Suspension/ Drops
- Syrup
- Tablet
- Tablet, Chewable, Extended Release
- Tablet, Orally Disintegrating
- Tape
 
- Routes
- Oral
- Respiratory (inhalation)
- Sublingual
- Topical
- Transdermal
- Transmucosal
 
- Prescription status
- OTC (over the counter)
- Marketed in the U.S.
- Since 1942
- Label revision date
- October 2, 2025
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Active ingredient
- Menthol 2.7 mg/2850 mg – 5 1/85 g
- Reference brand
- Natural Honey Herb Cough Suppressant Throat Drops
- Dosage forms
- Aerosol, Foam
- Aerosol, Spray
- Chewable Gel
- Cloth
- Cream
- Emulsion
- Gel
- Gel, Dentifrice
- Granule
- Granule, for Solution
- Liniment
- Lipstick
- Liquid
- Liquid, Extended Release
- Lotion
- Lozenge
- Mouthwash
- Oil
- Ointment
- Paste
- Paste, Dentifrice
- Pastille
- Patch
- Patch, Extended Release
- Plaster
- Powder
- Salve
- Soap
- Solution
- Spray
- Stick
- Suspension/ Drops
- Syrup
- Tablet
- Tablet, Chewable, Extended Release
- Tablet, Orally Disintegrating
- Tape
 
- Routes
- Oral
- Respiratory (inhalation)
- Sublingual
- Topical
- Transdermal
- Transmucosal
 
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 1942
- Label revision date
- October 2, 2025
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Equate Honey Lemon Cough Drops are lozenges designed to temporarily relieve coughs that may occur with a cold, as well as occasional minor throat irritation and soreness. Similarly, Equate SF Menthol Cough Drops serve the same purpose, providing relief from coughs and throat discomfort. Both products contain menthol, which is commonly used in cough suppressants to soothe the throat and reduce coughing.
In addition to cough drops, various topical analgesics, such as Biofreeze and other menthol-based creams and gels, are formulated to provide temporary relief from minor aches and pains associated with conditions like arthritis, backaches, strains, and sprains. These products typically contain menthol, which helps to cool and soothe the affected areas, offering a comforting sensation while alleviating discomfort.
Uses
You can use this product to temporarily relieve coughs that may occur with a cold, as well as to ease occasional minor irritation and soreness in your throat. Additionally, it can help alleviate minor aches and pains associated with conditions like arthritis, backaches, strains, and sprains.
For muscle and joint discomfort, this product is effective in providing temporary relief from soreness and stiffness. It is suitable for various situations, including muscle strains, bruises, and general discomfort in the affected areas.
Dosage and Administration
For adults and children aged 5 years and older, dissolve 1 lozenge slowly in your mouth every 2 hours as needed or as directed by a doctor. If you are under 5 years old, please consult a doctor before use.
For topical applications, adults and children aged 2 years and older can apply the product to the affected area not more than 3 to 4 times daily. If you are under 2 years old, consult a doctor before use. Always wash your hands after applying topical products.
For patches, adults and children aged 12 years and older should clean and dry the affected area, then apply the patch to the skin. You can wear one patch for up to 8 hours and repeat as necessary, but do not exceed 3 to 4 patches in a day. Children under 12 years should consult a physician before use.
What to Avoid
You should avoid using these products if you have certain conditions or if specific situations arise. Do not take or use these products if:
- You have a persistent or chronic cough, especially if it is accompanied by excessive phlegm, fever, rash, or a persistent headache, as these could indicate a serious condition. 
- You experience severe sore throat symptoms, or if irritation, pain, or redness lasts or worsens after 7 days. 
- You are pregnant or breastfeeding without consulting a healthcare professional. 
- You have allergies to any ingredients in the product. 
- You are epileptic or have high blood pressure. 
- You are using the product on wounds, damaged, or irritated skin, or if excessive irritation develops. 
- You are under 12 years of age with arthritis-like conditions. 
- You are using other topical analgesics or heating pads simultaneously. 
Additionally, keep these products out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately. Always consult a doctor if symptoms persist for more than 7 days or worsen.
Side Effects
If you are using cough drops or topical pain relief products, be aware of the following potential side effects and warnings:
- Cough Drops: If you experience a severe sore throat that lasts more than 2 days, or if it is accompanied by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly. These symptoms may indicate a serious condition. Additionally, if your cough persists for more than 7 days or is accompanied by fever or rash, seek medical advice. Sore mouth symptoms should improve within 7 days; if not, see a dentist or doctor. 
- Topical Pain Relief Products: These are for external use only. Avoid contact with eyes and do not apply to wounds or damaged skin. If you experience excessive redness, irritation, or if your condition worsens or persists for more than 7 days, discontinue use and consult a doctor. Some products may cause a transient burning sensation upon application, which should subside; however, if it becomes severe, stop using the product immediately. Always keep these products out of reach of children, and if ingested, seek medical help right away. 
Warnings and Precautions
If you are using any of the products mentioned, please be aware of the following important warnings and precautions:
- Sore Throat Warning: If you have a severe sore throat that lasts more than 2 days or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor immediately. These symptoms may indicate a serious condition. If sore mouth symptoms do not improve within 7 days, see your dentist or doctor. 
- Cough and Sore Throat: Stop using the product and call your doctor if your cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition. 
- Skin Application: For external use only. Avoid contact with eyes, mucous membranes, and broken or damaged skin. Do not bandage tightly or use with heating pads. If you experience excessive irritation, redness, or if your condition worsens, discontinue use and consult a doctor. 
- Emergency Help: If swallowed, seek medical help or contact a Poison Control Center immediately. Keep all products out of reach of children. 
- Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, consult a healthcare professional before use. 
Always read the product label for specific instructions and consult your healthcare provider if you have any concerns or questions about using these products.
Overdose
If you accidentally swallow or overdose on any of the products mentioned, it is crucial to seek medical help immediately or contact a Poison Control Center. Signs of overdose may vary, but common symptoms can include nausea, vomiting, or unusual reactions. Always keep these products out of reach of children to prevent accidental ingestion.
For specific products, if swallowed, you should contact a doctor or a Poison Control Center right away. This includes various gels, creams, sprays, and cough drops. If you experience any adverse effects after using these products, do not hesitate to seek professional assistance.
Pregnancy Use
If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using any of the following products. Many cough drops, pain relief gels, creams, and patches recommend seeking medical advice prior to use. This includes products like menthol cough drops, Biofreeze, and various topical analgesics.
While some products do not provide specific information regarding their safety during pregnancy, the general guideline is to err on the side of caution. Always discuss with your healthcare provider to ensure the safety of both you and your baby.
Lactation Use
If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using any medications or products. Many labels indicate that there is no specific information provided regarding the safety of these products for nursing mothers or their potential effects on lactation. Some products may have a risk of being excreted in breast milk, which means they could pass into your breast milk and potentially affect your infant.
Caution is advised when using products without clear guidance on their safety during breastfeeding, as the effects on nursing infants are often not well studied. Always prioritize your health and your baby's well-being by seeking professional advice.
Pediatric Use
You should be aware of specific guidelines when using various medications for children. For most lozenges, children under 5 years old should consult a doctor before use, while those aged 5 years and older can typically dissolve one lozenge slowly in their mouth every two hours as needed. For cough drops, children under 12 years should also ask a doctor before use.
When it comes to topical treatments like creams, gels, and sprays, children under 2 years of age generally require a physician's consultation. For children aged 2 years and older, these products can usually be applied to the affected area up to 3-4 times daily, but always keep them out of reach of children to prevent accidental ingestion. If any product is swallowed, seek medical help or contact a Poison Control Center immediately.
Geriatric Use
You may find that many over-the-counter products, such as cough drops, pain relief gels, and topical creams, do not provide specific information regarding their use in older adults. This means there are no established dosage adjustments, safety concerns, or special precautions outlined for elderly patients.
When using these products, it's important to monitor for any unusual reactions or side effects, especially if you have underlying health conditions or are taking other medications. If you have concerns or experience any adverse effects, consult your healthcare provider for personalized advice. Always ensure that any product you choose is suitable for your individual health needs.
Renal Impairment
When dealing with medications, it's important to be aware of how kidney health can affect their use. For some products, renal impairment may require dosage adjustments to ensure safety and effectiveness. If you have reduced kidney function, your healthcare provider may recommend monitoring your renal function regularly and adjusting your dosage based on your creatinine clearance levels. This is particularly crucial for those with significant renal impairment, as they may be at a higher risk for potential toxicity.
Always consult with your healthcare provider before starting any new medication, especially if you have known kidney issues. They can provide guidance tailored to your specific health needs.
Hepatic Impairment
You may be wondering about the safety of using various cough drops and topical pain relief products if you have liver issues. Based on the information available, there are no specific warnings, dosage adjustments, or monitoring requirements related to liver impairment for the products listed. This means that these products do not provide guidance on how to use them safely if you have liver problems.
However, it's always a good idea to consult with your healthcare provider before using any new medication or product, especially if you have existing health conditions. They can provide personalized advice based on your health history and current medications.
Drug Interactions
You can feel confident using products like cough drops, topical analgesics, and menthol creams, as no specific drug interactions or laboratory test interactions have been reported for most of these items. However, it's important to note that some topical treatments, such as certain gels and patches, should not be combined with other topical products or medical devices.
Always discuss your medications and any ongoing treatments with your healthcare provider. This is crucial to ensure your safety and to avoid any potential interactions that could affect your health.
Storage and Handling
To ensure the safety and effectiveness of your products, please follow these storage and handling guidelines:
- Storage Temperature: Most products should be stored at room temperature, ideally between 20-25°C (68-77°F). Some items can tolerate a range of 15-30°C (59-86°F). Avoid exposing them to excessive heat or direct sunlight, as this can compromise their quality. 
- Handling: Always check the packaging before use. Do not use any product if the bag or seal is torn or open. Keep all products tightly closed when not in use to maintain their integrity. 
- Disposal: If a product's seal is broken or if it has been opened, it is best to discard it to avoid any potential safety risks. Additionally, please recycle packaging where possible. 
By following these simple guidelines, you can help ensure that your products remain safe and effective for use.
Uses and Indications
This drug is indicated for the temporary relief of cough as may occur with a cold, and for the temporary relief of occasional minor irritation and sore throat. It is suitable for adults and children 12 years of age and older, with specific instructions to consult a doctor for children under 12 years.
Cough Relief
- Temporarily relieves cough due to cold or inhaled irritants. 
- Temporarily relieves occasional minor irritation and pain associated with sore throat or sore mouth. 
Pain Relief
This drug is also indicated for the temporary relief of minor aches and pains of muscles and joints associated with:
- Arthritis 
- Simple backache 
- Strains 
- Sprains 
- Bruises 
- Cramps 
Special Conditions
- For adults and children over 12 years, apply to the affected area no more than 3 times daily and do not wear the patch for more than 8 hours. 
- Consult a doctor for children under 12 years of age. 
Limitations of Use
- No teratogenic or nonteratogenic effects have been mentioned in the provided information. 
Dosage and Administration
Adults and children 5 years and older are instructed to dissolve 1 lozenge slowly in the mouth, repeating every 2 hours as needed or as directed by a healthcare professional. For children under 5 years, consultation with a doctor is recommended prior to use.
For topical applications, adults and children 2 years and older may apply the product to the affected area not more than 3 to 4 times daily. Children under 2 years should consult a physician before use. Specific instructions include cleaning and drying the affected area prior to application, and in some cases, massaging the product into the skin until fully absorbed.
For patches, adults and children 12 years and older should clean and dry the affected area, apply the patch to the skin, and may repeat as necessary, but not more than 3 to 4 times daily. Each patch should not be left on for more than 8 hours. Children under 12 years should consult a physician before use.
In all cases, if the product comes into contact with hands, it is advised to wash with soap and water.
Contraindications
Use of the products is contraindicated in the following situations:
- Do not apply to wounds, damaged, broken, or irritated skin. 
- Do not use with heating pads or devices. 
- Do not bandage tightly. 
- Avoid contact with eyes and mucous membranes. 
- Do not use if allergic to any ingredient in the product. 
- Do not use on infants or children under 12 years of age with arthritis-like conditions. 
- Do not use if pregnant or breastfeeding without consulting a healthcare professional. 
- Do not use if epileptic or if you have high blood pressure. 
- Do not use if excessive skin irritation develops or if symptoms persist for more than 7 days. 
- Do not use if the product's appearance has changed or if the tamper-evident seal is broken. 
- Do not use if you have persistent or chronic cough, such as occurs with smoking, asthma, or emphysema, or if cough is accompanied by excessive phlegm. 
- If swallowed, seek medical help or contact a Poison Control Center immediately. 
Consult a healthcare professional if conditions worsen or if symptoms clear up and recur within a few days.
Warnings and Precautions
Sore Throat Warnings Severe or persistent sore throat, especially if accompanied by fever, headache, rash, swelling, nausea, or vomiting, may indicate a serious condition. If sore throat symptoms persist for more than 2 days, consult a doctor promptly. If sore mouth symptoms do not improve within 7 days, see a dentist or doctor.
Cough Warnings Cough that persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache should prompt a consultation with a doctor, as these may be signs of a serious condition.
General Precautions
- For external use only. 
- Avoid contact with eyes and mucous membranes. 
- Do not apply to wounds, damaged, or irritated skin. 
- Do not bandage tightly or use with heating pads or devices. 
- If pregnant or breastfeeding, consult a health professional before use. 
- Keep out of reach of children. In case of accidental ingestion, seek medical help or contact a Poison Control Center immediately. 
Stop Use and Consult a Doctor
- If condition worsens or symptoms persist for more than 7 days. 
- If redness, irritation, or excessive skin discomfort develops. 
- If symptoms clear up and then recur within a few days. 
- If you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied. 
Emergency Medical Help In case of accidental ingestion, get medical help or contact a Poison Control Center immediately. If severe skin reactions occur, discontinue use and seek medical advice.
Laboratory Tests Consult a doctor before use if you have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, or if cough is accompanied by excessive phlegm (mucus).
Side Effects
Patients using various topical analgesics and cough drops should be aware of potential adverse reactions, which can vary in severity and frequency. The following summarizes the adverse reactions and warnings associated with these products:
Serious Adverse Reactions
- Sore Throat Warning: Severe or persistent sore throat accompanied by high fever, headache, rash, swelling, nausea, or vomiting may indicate a serious condition. Patients should consult a doctor promptly if these symptoms occur. This warning applies to multiple cough drop products, including those from brands such as Halls, Equate, and Freegells. 
- Consult a Doctor: If cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache, this may signal a serious condition requiring medical attention. 
Common Adverse Reactions
- Skin Reactions: Patients may experience skin irritation, redness, or burning sensations at the application site. If these symptoms persist for more than 7 days or worsen, patients should discontinue use and consult a doctor. 
- Transient Burning Sensation: Some products may cause a transient burning sensation upon application, which generally subsides over time. If the burning sensation is severe or persistent, patients should stop using the product. 
Warnings for Specific Conditions
- External Use Only: All products are for external use only. Patients should avoid contact with eyes, mucous membranes, and broken or damaged skin. 
- Do Not Bandage Tightly: Patients are advised not to bandage the area tightly or use heating pads in conjunction with these products, as this may exacerbate irritation or cause burns. 
- Pregnancy and Breastfeeding: Pregnant or breastfeeding women should consult a healthcare professional before using these products. 
Additional Considerations
- Flammability: Many topical analgesics are flammable and should be kept away from heat or open flames. 
- Keep Out of Reach of Children: All products should be stored out of reach of children. In case of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately. 
Summary of Stop Use Recommendations
Patients should stop using the product and consult a doctor if:
- Condition worsens or symptoms persist for more than 7 days. 
- Redness, irritation, or excessive skin reactions develop. 
- Symptoms clear up and then recur within a few days. 
This summary highlights the importance of monitoring for adverse reactions and seeking medical advice when necessary.
Drug Interactions
No specific drug interactions have been identified for the following products:
- Equate Sf Menthol Cough Drops (Lozenge) 
- Biofreeze (Spray) 
- Premier Value (Lozenge) 
- Smooth Gator Head-Ezz Analgesic (Cream) 
- Fortify (Oil) 
- Bae Sciences Menthol Muscle Rub (Lotion) 
- Miracle Foot Repair (Cream) 
- Discount Drug Mart (Lozenge) 
- Cough Drops (Pastille) 
- Healthwise Pain Relief (Spray) 
- Medi First Plus Cherry Cough Drops, Medi-First Cherry Cough Drops, Medique Medikoff Drops (Lozenge) 
- Green Guard Cough Drop Relief (Lozenge) 
- Halls (Lozenge) 
- Medfreeze Naturally Cool Pain Relief (Liquid) 
- Menthol (Paste) 
- 4jointz (Cream) 
- Mgc Health Cough Drops (Lozenge) 
- Exchange Select Cough Drops (Lozenge) 
- Chinese Red Tiger Plaster (Patch) - Note: Do not use with other ointments, creams, sprays, or liniments. 
- Cold Therapy (Gel) - Note: Do not use with other ointments, creams, sprays, or liniments. 
- Budpack (Gel) 
- Walgreens Medicated Foot Powder (Powder) 
- Gutong Tiegao Pain Relieving (Plaster) 
- Ez Massager 2 (Gel) 
- Lilas Period (Patch) 
- Healthwise Overnight Menthol Patch (Patch) - Note: Do not use at the same time as other topical analgesics. 
- Pain Relieving Cold Therapy (Gel) - Note: Do not combine with any other topical treatments or use with any medical device. 
- Mckesson Sugar Free Cough Suppressant Oral Anesthetic (Lozenge) 
- Zhuanggu Gao Pain Relieving (Plaster) 
- Recovery (Ointment) 
- Caring Mills Menthol 4% Roll-on (Gel) 
- Mgc Health (Tablet, Chewable, Extended Release) 
- Biofreeze Overnight Roll-on (Gel) 
- Theracare Roll-on Menthol 4% Pain Relief (Gel) 
- Sugarloaf Organics Menthol Revive (Cream) 
- Eco Lips Menthol Medicated Lip Balm (Stick) 
- Control Menstrual Cramp Relief (Cream) 
Additionally, no drug and laboratory test interactions have been reported for these products.
Pediatric Use
Pediatric patients may require special considerations when using various medications. The following summarizes the pediatric use information across multiple products:
Age-Specific Recommendations
- Children under 2 years: - Consult a physician before use for all products. 
 
- Children 2 years and older: - Many products can be applied or administered, but specific instructions vary: - Topical applications (creams, gels, sprays): Generally safe for children 2 years and older, with a maximum application of 3 to 4 times daily. 
- Lozenges: Typically recommended for children 2 years and older, with specific instructions to dissolve slowly in the mouth and repeat every 2 hours as needed. 
 
 
- Children under 5 years: - Ask a doctor before use for lozenges and other medications. 
 
- Children 5 years and older: - Generally, medications can be used as directed for adults, with specific dosages often mirroring those for adults. 
 
- Children under 12 years: - Many products advise consulting a physician before use, particularly for topical analgesics and cough drops. 
 
Dosage and Administration
- Lozenges: - For children 2 years and older, dissolve slowly in the mouth, repeating every 2 hours as needed. Children under 5 years should consult a doctor before use. 
 
- Topical Products: - Apply to the affected area not more than 3 to 4 times daily for children 2 years and older. For children under 2 years, consult a physician. 
 
Safety Precautions
- All products should be kept out of reach of children to prevent accidental ingestion. In case of accidental ingestion, seek medical help or contact a Poison Control Center immediately. 
- Specific warnings apply to children under 12 years for certain products, advising against use unless directed by a physician. 
Summary
Pediatric patients should be carefully monitored when using medications, particularly those under 12 years of age. Consultation with a healthcare provider is recommended for children under 5 years and for all children when using topical analgesics or cough drops.
Geriatric Use
No specific information regarding geriatric use, dosage adjustments, safety concerns, or special precautions for elderly patients is provided in the drug inserts for the products reviewed. Therefore, healthcare professionals should exercise caution when prescribing these medications to geriatric patients, as the absence of data may indicate a lack of established safety or efficacy in this population. Monitoring for potential adverse effects and adjusting dosages as necessary based on individual patient response is recommended.
Pregnancy
Pregnant patients should consult a healthcare professional before using any of the products listed, as many do not have established safety profiles during pregnancy. The following precautions are advised:
- General Precaution: For most products, including various cough drops, gels, creams, and patches, it is recommended that pregnant or breastfeeding individuals seek medical advice prior to use. This includes products such as menthol cough drops, pain relief gels, and topical analgesics. 
- Specific Contraindications: Certain products explicitly advise against use during pregnancy. For example, some formulations of pain relief products and cough drops indicate that they should not be used if pregnant or breastfeeding. 
- Safety Concerns: The safety of many ingredients, particularly menthol, during pregnancy has not been fully established. Pregnant patients should be cautious and discuss potential risks with their healthcare provider. 
- Dosage Modifications: There are no specific dosage modifications provided for pregnant individuals across the majority of products. Consultation with a healthcare provider is essential for personalized guidance. 
- Fetal Impact: Some products may pose potential risks to the fetus, and further studies are needed to determine their safety. Pregnant patients should only use these products if clearly needed and after discussing with a healthcare provider. 
In summary, the overarching recommendation for all products is to consult a healthcare professional before use during pregnancy or breastfeeding to ensure safety and appropriateness.
Lactation
Lactating mothers are advised to consult a healthcare professional before using various products, particularly those labeled for pain relief or cough suppression. Many products, including lozenges and topical treatments, do not provide specific information regarding their safety during lactation or the potential for excretion in breast milk.
For instance, some products explicitly state that nursing mothers should seek medical advice prior to use, as the effects on breastfed infants are not well studied. Caution is particularly emphasized for products like Mgc Health Cough Drops, which indicate a potential for excretion in breast milk and recommend consulting a doctor due to the unknown effects on nursing infants.
While several labels lack specific warnings or recommendations for nursing mothers, it remains prudent for lactating individuals to approach the use of any medication or topical treatment with caution. The absence of data does not imply safety, and healthcare professionals can provide guidance tailored to individual circumstances.
Renal Impairment
Patients with renal impairment may require careful consideration regarding the use of certain medications. For those with reduced kidney function, dosage adjustments may be necessary to avoid potential toxicity. It is recommended that renal function tests be conducted regularly to monitor the patient's condition.
Specifically, for patients with a creatinine clearance of less than 30 mL/min, a reduced dose should be considered. Special monitoring is advised for patients with significant renal impairment to ensure safety and efficacy of the treatment.
In summary, healthcare providers should assess renal function prior to initiating therapy and adjust dosages accordingly for patients with renal impairment to mitigate risks associated with medication use.
Hepatic Impairment
Patients with hepatic impairment may not require specific dosage adjustments, special monitoring, or precautions when using the products listed. The available inserts for these products do not provide any information regarding the effects of hepatic impairment on their pharmacokinetics or safety profiles. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing these products to patients with liver conditions. Regular monitoring of liver function tests may be advisable to ensure patient safety, although specific parameters are not outlined in the product information.
Overdosage
In cases of overdose, it is crucial to seek medical help or contact a Poison Control Center immediately. Symptoms of overdose may vary depending on the specific product ingested, but general recommendations include monitoring for any adverse reactions and providing supportive care as needed.
For products such as Biofreeze, if accidentally ingested, individuals should get medical help or contact a Poison Control Center right away. Similarly, for products like Cannarelief and various menthol-based creams and gels, immediate medical assistance is advised if swallowed.
Specific products, including various cough drops and topical analgesics, also emphasize the importance of contacting a healthcare professional or poison control center in the event of accidental ingestion. This includes items like the Menthol Cough Drops, which instruct users to seek help if an overdose occurs.
In summary, the recommended action for any suspected overdose is to obtain medical assistance promptly, as timely intervention can mitigate potential health risks associated with the ingestion of these products.
Nonclinical Toxicology
Teratogenic Effects
No teratogenic effects were observed in animal studies for certain products, including those labeled as "Cbd Menthol Pain Relief" and "Pain Relief." However, some products explicitly advise against use during pregnancy or breastfeeding, such as "Fortify," "Pain Relief," and "Cvs Pain Relief," recommending consultation with a health professional.
Non-Teratogenic Effects
Animal studies did not indicate any increase in fetal malformations for products like "Cbd Menthol Pain Relief" and "Pain Relief." Nonetheless, several products lack specific information regarding non-teratogenic effects.
Nonclinical Toxicology
The nonclinical toxicology sections for many products do not provide relevant information. Notably, products such as "Cbd Menthol Pain Relief" and "Pain Relief" indicate that no adverse developmental outcomes were observed in animal studies. However, the majority of labels reviewed do not contain any nonclinical toxicology data.
Animal Pharmacology and Toxicology
Animal pharmacology and toxicology data are generally absent across the reviewed products. Where available, studies have not shown any significant adverse effects. For instance, "Cbd Menthol Pain Relief" and "Pain Relief" report no adverse developmental outcomes in animal studies.
Storage and Handling
Equate Honey Lemon Cough Drops, Equate Sf Menthol Cough Drops, and various other cough drop products are supplied in lozenge form. It is important to note that these products should not be used if the bag is torn or open.
Biofreeze and Biofreeze Professional are available in spray and aerosol forms. These products should be stored in a cool, dry place, away from excessive heat or open flame, and should not be stored at temperatures above 120°F. Biofreeze Professional should be kept at 20-25°C (68-77°F) and away from direct sunlight.
Saint is supplied as a liquid and should be stored strictly away from light and kept at low temperatures. Cannarelief products, available in salve form, should be stored at 68-77°F and protected from direct sunlight.
For patches, such as the Signature Care Medicated Cold and Hot Patch and various menthol patches, storage should be at room temperature, not exceeding 86°F (30°C). They should be kept away from excessive moisture and direct sunlight.
Lozenges, including those from Premier Value, Mgc Health, and Quality Choice, generally do not have specific storage instructions but should be kept in a cool, dry place. Some products, like the Herbal Cough Drops and Natural Honey Herb Cough Suppressant Throat Drops, should also be stored in a dry place.
Gel and cream products, such as Pain Relief Gel and various topical analgesics, should be stored in a cool, dry place, with lids tightly closed. Many of these products specify a storage temperature range of 20-25°C (68-77°F) and should be protected from light and excessive heat.
In summary, products should be stored according to their specific requirements, with a focus on maintaining appropriate temperature ranges, protecting from light and moisture, and ensuring that containers are tightly closed to preserve product integrity.
Product Labels
The table below lists all over-the-counter labels containing menthol. Use it to compare dosage forms, strengths, and uses across products.
| More Details | |||||
|---|---|---|---|---|---|
| ARP (USA) Pty Ltd | Cream | Topical | 1.5 g/100 g | 2017 | |
| 
 Indications
 | |||||
| Rinati Skin, LLC | Cream | Topical | 0.1 g/1 mL | 2021 | |
| 
 Indications
 | |||||
| MENPER DISTRIBUTORS INC. | Gel | Topical | 5 mg/100 mL | 2021 | |
| 
 Indications
 | |||||
| Clarion Brands, LLC | Patch | Topical | 5000 mg/1 h | 2018 | |
| 
 Indications
 | |||||
| Clarion Brands LLC. | Patch | Topical | 7500 mg/1 h | 2024 | |
| 
 Indications
 | |||||
| Clarion Brands LLC | Patch | Topical | 7500 mg/1 h | 2024 | |
| 
 Indications
 | |||||
| Clarion Brands, LLC | Patch | Topical | 6500 mg/1 h | 2015 | |
| 
 Indications
 | |||||
| Clarion Brands, LLC | Liquid | Topical | 4 g/100 mL | 2010 | |
| 
 Indications
 | |||||
| Clarion Brands, LLC | Patch | Topical | 7500 mg/1 h | 2024 | |
| 
 Indications
 | |||||
| Kelada Creative Group LLC DBA SALVE | Cream | Topical | 28 g/90 mL | 2016 | |
| 
 Indications
 | |||||
| EXECUTIVE PRO SOLUTIONS DOO | Gel | Topical | 12 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| 8.0 IDEAL BALANCE D. O. O. BEOGRAD | Cream | Topical | 70 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| 8.0 IDEAL BALANCE D. O. O. BEOGRAD | Gel | Topical | 12 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Medline Industries, LP | Gel | Topical | 80 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Medline Industries, LP | Spray | Topical | 80 g/1000 g | 2019 | |
| 
 Indications
 | |||||
| Medline Industries, LP | Liquid | Topical | 80 g/1000 g | 2019 | |
| 
 Indications
 | |||||
| Medline Industries, LP | Spray | Topical | 100 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Family First Pharmaceuticals, Inc. | Stick | Topical | 0.05138 g/1 g | 2011 | |
| 
 Indications
 | |||||
| Family First Pharmaceuticals, Inc. | Stick | Topical | 0.05138 g/1 g | 2017 | |
| 
 Indications
 | |||||
| INNOVATIONS FOR WELLNESS, LLC | Solution | Topical | 35 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Innovations for Wellness, LLC | Cream | Topical | 35 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Liquid | Topical | 1.05 g/84 g | 2020 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2020 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Cream | Topical | 0.2 g/4 g | 2020 | |
| 
 Indications
 | |||||
| Crosstown Concepts Corporation | Cream | Topical | 5.6 g/112 g | 2020 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2020 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Cream | Topical | 0.2 g/4 g | 2020 | |
| 
 Indications
 | |||||
| U. S. A. AH LLC | Patch | Topical | 30 mg | 2013 | |
| 
 Indications
 | |||||
| Tianjin Oculax Biotech Inc | Patch | Topical | 2.5 mg/100 mg | 2018 | |
| 
 Indications
 | |||||
| Global Products Group, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Indiana Botanic Gardens | Ointment | Topical | 0.31 g/100 g | 1995 | |
| 
 Indications
 | |||||
| Amazon. com Services LLC | Patch | Topical | 5 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Amish Origins Management, LLC | Spray | Topical | 80 mg/1 mL | 2001 | |
| 
 Indications
 | |||||
| Amish Origins Management, LLC | Cream | Topical | 80 mg/1 g | 2001 | |
| 
 Indications
 | |||||
| Amish Origins Management, LLC | Ointment | Topical | 80 mg/1 g | 2001 | |
| 
 Indications
 | |||||
| COASTAL FORMULAS LLC | Cream | Topical | 80 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| COASTAL FORMULAS LLC | Cream | Topical | 80 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Ouwee Jones, LLC | Spray | Topical | 700 mL/1 L | 2011 | |
| 
 Indications
 | |||||
| Safetec of America, Inc. | Spray | Topical | 70 mg/1 L | 2018 | |
| 
 Indications
 | |||||
| Safetec of America, Inc. | Gel | Topical | 70 mg/1 L | 2018 | |
| 
 Indications
 | |||||
| Safetec of America, Inc. | Spray | Topical | 70 mg/1 mL | 2011 | |
| 
 Indications
 | |||||
| ANC Amazon Natural Corp. | Spray | Topical | 5 mL/100 mL | 2011 | |
| 
 Indications
 | |||||
| Pharmanuco | Spray | Topical | 5 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Spray | Topical | 10 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3.2 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3.2 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3.2 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3 g/100 mL | 2017 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3 g/100 mL | 2017 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3 g/100 mL | 2017 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 3 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Liquid | Topical | 3 g/100 mL | 2016 | |
| 
 | |||||
| Pharmanuco | Gel | Topical | 2.5 g/100 mL | 2016 | |
| 
 | |||||
| STRATUS PHARMACEUTICALS INC | Gel | Topical | 3.969 g/113.4 g | 2017 | |
| 
 Indications
 | |||||
| Clinical Resolution Laboratory, Inc. | Cream | Topical | 40 mg/1 g | 2018 | |
| 
 Indications
 | |||||
| WYNNPHARM INC. | Gel | Topical | 30 mg/1 g | 2022 | |
| 
 Indications
 | |||||
| Marketites LLC | Lotion | Topical | 1 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Marketites LLC | Lotion | Topical | 1 g/100 g | 2025 | |
| 
 Indications
 | |||||
| Marketites LLC | Lotion | Topical | 1 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Pure Science International, Inc. | Cream | Topical | 5 g/100 g | 2007 | |
| 
 Indications
 | |||||
| RZN Nutraceuticals, Inc. | Cream | Topical | 5 g/100 g | 2007 | |
| 
 Indications
 | |||||
| NDI Solutions LLC | Cream | Topical | 12.5 mg/1 g | 2010 | |
| 
 Indications
 | |||||
| Smith Amish, LLC | Cream | Topical | 1.25 g/100 g | 2024 | |
| 
 Indications
 | |||||
| NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 mL | 2017 | |
| 
 Indications
 | |||||
| NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 g | 2012 | |
| 
 Indications
 | |||||
| NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 g | 2017 | |
| 
 Indications
 | |||||
| NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 g | 2013 | |
| 
 Indications
 | |||||
| NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 mL | 2017 | |
| 
 Indications
 | |||||
| G2 Products LLC | Cream | Topical | 1.4125 g/113 g | 2020 | |
| 
 Indications
 | |||||
| G2 Products LLC | Cream | Topical | 1.4125 g/113 g | 2020 | |
| 
 Indications
 | |||||
| G2 Products LLC | Cream | Topical | 1.4125 g/113 g | 2020 | |
| 
 Indications
 | |||||
| BIOBEST SERVICES LLC | Cream | Topical | 15 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Caribe Natural, Inc | Gel | Topical | 1 g/100 g | 2015 | |
| 
 | |||||
| World Perfumes, Inc | Gel | Topical | 1 g/100 g | 2015 | |
| 
 | |||||
| Akron Pharma Inc. | Patch | Topical | 210 mg | 2021 | |
| 
 Indications
 | |||||
| Greenbrier International, Inc. | Gel | Topical | 2.5 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Greenbrier International, Inc | Patch | Topical | 5 mg/100 mg | 2014 | |
| 
 | |||||
| Greenbrier International, Inc. | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Greenbrier International, Inc. | Gel | Topical | 1.25 g/100 g | 2011 | |
| 
 Indications
 | |||||
| ASTONEA LABS PRIVATE LIMITED | Gel | Topical | 4.54 g/227 g | 2019 | |
| 
 Indications
 | |||||
| ASTONEA LABS PRIVATE LIMITED | Gel | Topical | 4 g/100 g | 2024 | |
| 
 Indications
 | |||||
| ASTONEA LABS PRIVATE LIMITED | Gel | Topical | 5 g/100 g | 2016 | |
| 
 Indications
 | |||||
| BIOCARE LABS INC. | Gel, Dentifrice | Topical | 10 mg/1 g | 2014 | |
| 
 Indications
 | |||||
| NeoPharm Co. , Ltd. | Gel | Topical | 2.5 g/100 g | 2012 | |
| 
 Indications
 | |||||
| NeoPharm Co. , Ltd. | Cream | Topical | 10 g/100 g | 2012 | |
| 
 Indications
 | |||||
| SHENZHEN YUWEN E-COMMERCE CO. , LTD. | Patch | Topical | 470 mg | 2023 | |
| 
 Indications
 | |||||
| SHENZHEN YUWEN E-COMMERCE CO. , LTD. | Solution | Topical | 4 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| ADP Health Limited | Gel | Topical | 4 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| ADP Health Limited | Cream | Topical | 4 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| Unipack, Inc. | Gel | Topical | 2 g/100 g | 2017 | |
| 
 Indications
 | |||||
| Unipack LLC | Spray | Topical | 9 g/100 mL | 2014 | |
| 
 | |||||
| QUALITY CHOICE (Chain Drug Marketing Association) | Patch | Topical | 5 g | 2019 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Lotion | Topical | 5 g/95 g | 2023 | |
| 
 Indications
 | |||||
| Jonathan International, Inc. | Liniment | Topical | 3.7 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| KTAIGA CO. , LTD. | Gel | Topical | 3 g/120 mL | 2012 | |
| 
 Indications
 | |||||
| Amazon. com | Lozenge | Oral | 5.8 mg | 2021 | |
| 
 Indications
 | |||||
| Amazon. com | Lozenge | Oral | 7.5 mg | 2021 | |
| 
 Indications
 | |||||
| Amazon. com | Lozenge | Oral | 7.6 mg | 2021 | |
| 
 Indications
 | |||||
| Amazon. com | Lozenge | Oral | 5.8 mg | 2021 | |
| 
 Indications
 | |||||
| SAVE-A-LOT FOOD STORES, LTD. | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| BLOOMWELL GARDENS LLC | Cream | Topical | 5 g/100 g | 2025 | |
| 
 Indications
 | |||||
| Kenvue Brands LLC | Patch | Topical | 50 mg | 2019 | |
| 
 Indications
 | |||||
| Kenvue Brands LLC | Gel | Topical | 25 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| Geritrex LLC | Gel | Topical | 5.085 g/113 g | 2015 | |
| 
 | |||||
| Geritrex LLC | Spray | Topical | 11.8 g/118 mL | 2015 | |
| 
 Indications
 | |||||
| Bestco LLC | Lozenge | Oral | 5.4 mg | 2022 | |
| 
 Indications
 | |||||
| Bestco LLC | Lozenge | Oral | 4.8 mg | 2021 | |
| 
 Indications
 | |||||
| BioChemics, Inc. | Lotion | Topical | 5.11 g/113 g | 2011 | |
| 
 Indications
 | |||||
| POLIMEROS Y SERVICIOS S. A. | Gel | Topical | 30 mg/1 g | 2019 | |
| 
 | |||||
| JJindustry. Co. Ltd | Gel | Topical | 4.0 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| JJindustry. Co. Ltd | Gel | Topical | 4.0 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| JJindustry. Co. Ltd | Gel | Topical | 2.1 g/60 mL | 2018 | |
| 
 Indications
 | |||||
| Health Care Laboratories Inc. | Gel | Topical | 0.03 g/1 g | 1998 | |
| 
 Indications
 | |||||
| Health Care Laboratories Inc. | Gel | Topical | 3 g/100 g | 1998 | |
| 
 Indications
 | |||||
| Performance Health, LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Spray | Topical | 105 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Cream | Topical | 100 mg/1 g | 2024 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Spray | Topical | 105 mg/1 mL | 2014 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Spray | Topical | 100 mg/1 mL | 2010 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 35 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Patch | Topical | 0.05 g/1 g | 2022 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2012 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Cream | Topical | 100 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2012 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2013 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Stick | Topical | 0.15 g/1 g | 2024 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Patch | Topical | 56 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Liquid | Topical | 70 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Cream | Topical | 100 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Patch | Topical | 0.3 g/6 g | 2022 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Liquid | Topical | 105 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Aerosol, Spray | Topical | 105 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Spray | Topical | 105 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2013 | |
| 
 Indications
 | |||||
| Scientific Solutions Global Llc | Liquid | Topical | 10 g/100 mL | 2017 | |
| 
 Indications
 | |||||
| Scientific Solutions Global, LLC | Gel | Topical | 10 g/100 mL | 2017 | |
| 
 Indications
 | |||||
| Scientific Solutions Global, LLC | Cream | Topical | 10 g/100 mL | 2017 | |
| 
 Indications
 | |||||
| Scientific Solutions Global, LLC | Spray | Topical | 10 g/100 mL | 2017 | |
| 
 Indications
 | |||||
| Boston Nutraceutical Production SL | Pastille | Oral | 5.8 mg | 2019 | |
| 
 Indications
 | |||||
| Carbon Biotech Llc | Patch | Topical | 0.156 g | 2018 | |
| 
 Indications
 | |||||
| Carbon Biotech Llc | Patch | Topical | 0.348 g | 2018 | |
| 
 Indications
 | |||||
| Floratech Botanicals, LLC | Salve | Topical | 1 g/100 g | 2016 | |
| 
 Indications
 | |||||
| Blistex Inc | Soap | Topical | 1 g/100 mL | 2008 | |
| 
 Indications
 | |||||
| Blistex Inc. | Powder | Topical | 1 g/100 g | 2015 | |
| 
 Indications
 | |||||
| JMD All Star Impex Inc | Gel | Topical | 2 g/100 g | 2010 | |
| 
 Indications
 | |||||
| JT Cosmetics and Chemicals | Gel | Topical | 2 g/100 g | 2015 | |
| 
 Indications
 | |||||
| Navarro Discount Pharmacies, LLC | Gel | Topical | .02 g/1 g | 2012 | |
| 
 Indications
 | |||||
| Delon Laboratories (1990) Ltd | Gel | Topical | 2 g/100 g | 2010 | |
| 
 Indications
 | |||||
| Select Brand Distributors | Gel | Topical | 2.0 g/100 g | 2014 | |
| 
 Indications
 | |||||
| ACA MANAGEMENT LLC | Cream | Topical | 27.5 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| ACA MANAGEMENT LLC | Cream | Topical | 14 mg/1 mL | 2025 | |
| 
 Indications
 | |||||
| Budpack Inc. | Gel | Topical | 2.5 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Budpak Inc. | Gel | Topical | 0.025 g/1 g | 2012 | |
| 
 Indications
 | |||||
| Jiashen International Trade Limited | Liquid | Topical | 21 mg/1 g | 2025 | |
| 
 | |||||
| Welly Health PBC | Cream | Topical | 1.5 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Sklar BOV Solutions Inc | Spray | Topical | 105 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| Quantum, Inc. | Liquid | Topical | 5 mg/1 mL | 2003 | |
| 
 Indications
 | |||||
| Carolina Cannabis Creations LLC | Salve | Topical | 7.9 g/71.9 g | 2023 | |
| 
 Indications
 | |||||
| Earthmed LLC | Salve | Topical | 7.9 g/71.9 g | 2023 | |
| 
 Indications
 | |||||
| New World Imports, Inc | Gel | Topical | 25 mg/1 g | 2012 | |
| 
 Indications
 | |||||
| American Sales Company | Patch | Topical | 0.05 mg | 2019 | |
| 
 | |||||
| American Sales Company | Patch | Topical | 0.05 mg | 2014 | |
| 
 | |||||
| FSA STORE INC. | Lozenge | Oral | 5.8 mg | 2024 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Gel | Topical | 4 g/1 mL | 2025 | |
| 
 Indications
 | |||||
| Aidance Skincare & Topical Solutions, LLC | Oil | Topical | 0.08 kg/1 kg | 2017 | |
| 
 Indications
 | |||||
| Aidance Skincare & Topical Solutions, LLC | Cream | Topical | 4 g/100 g | 2015 | |
| 
 Indications
 | |||||
| Aidance Skincare & Topical Solutions, LLC | Oil | Topical | 8 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| Aidance Skincare & Topical Solutions, LLC | Cream | Topical | 4 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Global Widget, LLC | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Global Products Group, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Global Widget, LLC | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Global Products Group, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| SmartScience Laboratories, Inc. | Gel | Topical | 85 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| ENDEXX CORPORATION | Cream | Topical | 125 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| ENDEXX CORPORATION | Cream | Topical | 1.25 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| AIDANCE SKINCARE & TOPICAL SOLUTIONS, LLC | Cream | Topical | 40 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| AIDANCE SKINCARE & TOPICAL SOLUTIONS, LLC | Cream | Topical | 40 mg/1 g | 2019 | |
| 
 | |||||
| Factors Group of Nutritional Products | Cream | Topical | 12.5 mg/1 g | 2012 | |
| 
 Indications
 | |||||
| Natural Factors Nutritional Products Ltd | Cream | Topical | 1.5 g/100 g | 2007 | |
| 
 Indications
 | |||||
| PharmaNutra Usa Corp. | Cream | Topical | 1.4 g/100 g | 2025 | |
| 
 Indications
 | |||||
| Ixxa, Inc. | Patch | Topical | 10 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Tibet Cheezheng Tibetan Medicine Co. Ltd | Cream | Topical | 5 g/100 g | 2024 | |
| 
 Indications
 | |||||
| American Sales | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| BestCo Inc. | Lozenge | Oral | 5.8 mg | 2015 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| Rite Aid | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| Rite Aid | Lozenge | Oral | 5.8 mg | 2015 | |
| 
 Indications
 | |||||
| Safeway Inc. | Lozenge | Oral | 5.8 mg | 2014 | |
| 
 Indications
 | |||||
| The Kroget Co. | Lozenge | Oral | 5.8 mg | 2014 | |
| 
 Indications
 | |||||
| Walgreen Co. | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| 7-Eleven Inc. | Lozenge | Oral | 5.8 mg | 2015 | |
| 
 Indications
 | |||||
| American Sales | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Accociation | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 5.8 mg | 2015 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Family Dollar | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| Family Dollar | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| Publix | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| Safeway | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| TopCo Associates | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| TopCo Associates | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. dba UNFI | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| Valu Merchandisers | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| Walgreen Co. | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Walmart Stores Inc. | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Walmart Stores Inc. | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Whole Foods Market | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| Winco Foods | Lozenge | Oral | 5.8 mg | 2014 | |
| 
 Indications
 | |||||
| JHK Inc dba American Safety & First Aid | Lozenge | Oral | 7.6 mg | 2000 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Salve | Topical | 27.6 mg/1 g | 2016 | |
| 
 | |||||
| Guangzhou Su Mai Feng International Trading Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2025 | |
| 
 Indications
 | |||||
| TIANJIN DARENTANG JINGWANHONG PHARMACEUTICAL CO. , LTD. | Ointment | Topical | 1 g/100 g | 2023 | |
| 
 Indications
 | |||||
| My Import Inc | Gel | Topical | 2 g/100 g | 2010 | |
| 
 Indications
 | |||||
| MDR Fitness Corp. | Gel | Topical | 1 mg/100 mL | 2014 | |
| 
 Indications
 | |||||
| Clean Remedies, LLC | Cream | Topical | 20 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| MAGVERZ INC | Spray | Topical | 16 g/100 mL | 2013 | |
| 
 Indications
 | |||||
| MAGVERZ INC | Cream | Topical | 0.075 g/1 g | 2013 | |
| 
 Indications
 | |||||
| The Mentholatum Company | Patch | Topical | 240–500 mg | 2014 | |
| 
 Indications
 | |||||
| Universal Distribution Center LLC | Patch | Topical | 0.05 g/1 g | 2024 | |
| 
 Indications
 | |||||
| Universal Distribution Center LLC | Patch | Topical | 0.05 g/1 g | 2024 | |
| 
 Indications
 | |||||
| Valu Merchandisers Company, Inc. | Patch | Topical | 875 mg | 2011 | |
| 
 Indications
 | |||||
| Valu Merchandisers Company, Inc. | Patch | Topical | 550 mg | 2022 | |
| 
 Indications
 | |||||
| Valu Merchandisers Company, Inc. | Patch | Topical | 400 mg | 2011 | |
| 
 Indications
 | |||||
| CareOne | Liquid | Topical | 16 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| Navarro Discount Pharmacies, LLC | Patch | Topical | 400 mg | 2012 | |
| 
 Indications
 | |||||
| Navarro Discount Pharmacies, LLC | Patch | Topical | 400 mg | 2012 | |
| 
 Indications
 | |||||
| Kareway Product, Inc. | Patch | Topical | 400 mg | 2012 | |
| 
 Indications
 | |||||
| Guangzhou Zhupuyou E-commerce Co. , Ltd | Patch | Topical | 0.05 g/1 g | 2025 | |
| 
 Indications
 | |||||
| Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| InterMed Laboratories Private Limited | Patch | Topical | 5 g | 2025 | |
| 
 Indications
 | |||||
| InterMed Laboratories Private Limited | Patch | Topical | 5 g | 2025 | |
| 
 Indications
 | |||||
| Quality Choice | Patch | Topical | 5 g | 2025 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g | 2025 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g | 2025 | |
| 
 Indications
 | |||||
| Simple Diagnostics, Inc. | Patch | Topical | 5 g/100 g | 2015 | |
| 
 Indications
 | |||||
| Zhejiang Bangli Medical Products CO. , LTD | Patch | Topical | 5 g/100 g | 2014 | |
| 
 Indications
 | |||||
| Dabur India Limited | Gel | Topical | 4.54 g/227 g | 2019 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Gel | Topical | 37 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| AHC Ventures Corp DBA Cryoderm | Spray | Topical | 10 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| Kroger | Spray | Topical | 10.5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Meijer | Gel | Topical | 4 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Walgreen Co. | Gel | Topical | 36 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| WALGREEN COMPANY | Spray | Topical | 10.5 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Meijer | Spray | Topical | 10.5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Amerisource Bergen | Spray | Topical | 10.5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Meijer | Gel | Topical | 4 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Allegiant Health | Gel | Topical | .04 g/1 mL | 2025 | |
| 
 Indications
 | |||||
| SOTAC PHARMACEUTICALS PRIVATE LIMITED | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Yash Pharmaceuticals | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Shopko Stores Operating Co. , LLC | Patch | Topical | 5 g | 2017 | |
| 
 Indications
 | |||||
| Dynarex Corporation | Patch | Topical | 100 mg/5 mg | 2018 | |
| 
 Indications
 | |||||
| PRINCE OF PEACE ENTERPRISES INC. | Granule, for Solution | Oral | 490 mg/5 g | 2010 | |
| 
 Indications
 | |||||
| Envisionate PSJ LLC | Ointment | Topical | 1 g/100 g | 2019 | |
| 
 | |||||
| PMS4PMS LLC | Cream | Topical | 40 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| AMERISOURCE BERGEN | Liquid | Topical | 16 mg/100 mL | 2023 | |
| 
 Indications
 | |||||
| Top Care | Spray | Topical | 16 g/100 g | 2013 | |
| 
 Indications
 | |||||
| Bionpharma Inc. | Liquid | Topical | 16 mg/100 mL | 2022 | |
| 
 Indications
 | |||||
| Acutens | Gel | Topical | 16 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Evora Worldwide | Liquid | Topical | 16 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| COOL BREEZE US LLC | Gel | Topical | 51 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| NeilMed Pharmaceuticals, Inc. | Spray | Topical | 160 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Walgreens | Spray | Topical | 160 mg/1 mL | 2013 | |
| 
 Indications
 | |||||
| Walgreen Co. | Patch | Topical | .05 mg/1 g | 2013 | |
| 
 Indications
 | |||||
| Walgreen Co. | Patch | Topical | .05 mg/1 g | 2013 | |
| 
 Indications
 | |||||
| FULL EIGHT Inc | Gel | Topical | 1.2 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| Walgreen Company | Cream | Topical | 4.5 g/100 g | 2025 | |
| 
 Indications
 | |||||
| Walgreens | Gel | Topical | 2.5 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| Tommie Copper, Inc. | Spray | Topical | 16 g/100 g | 2021 | |
| 
 Indications
 | |||||
| United Exchange Corp. | Gel | Topical | .02 g/1 g | 2016 | |
| 
 | |||||
| United Exchange Corp. | Patch | Topical | 210 mg | 2023 | |
| 
 | |||||
| United Exchange Corp. | Patch | Topical | 5 mg | 2019 | |
| 
 | |||||
| United Exchange Corp. | Patch | Topical | 5 mg/1 g | 2013 | |
| 
 | |||||
| United Exchange Corp. | Patch | Topical | 50 mg/1 g | 2014 | |
| 
 | |||||
| United Exchange Corp. | Patch | Topical | 336 mg | 2016 | |
| 
 | |||||
| United Exchange Corp. | Patch | Topical | 336 mg | 2016 | |
| 
 | |||||
| CVS Pharmacy | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Perrigo Direct Inc. | Pastille | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| Perrigo Direct Inc. | Pastille | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| Perrigo Direct Inc. | Pastille | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Perrigo Direct, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Perrigo Direct, Inc. | Pastille | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| The Kroger CO | Pastille | Oral | 5.4 mg | 2022 | |
| 
 Indications
 | |||||
| The Kroger CO | Pastille | Oral | 5.4 mg | 2022 | |
| 
 Indications
 | |||||
| The Kroger CO | Pastille | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| The Kroger CO | Pastille | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| The Kroger CO | Pastille | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 7.5 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 5.4 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 7.5 mg | 2022 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. | Pastille | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. | Pastille | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. | Pastille | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Misero Biotechnology Co, Ltd | Tablet, Orally Disintegrating | Sublingual | 5.4 mg | 2024 | |
| 
 Indications
 | |||||
| Xinsanyang Pharmaceutical (Xiamen) Co. , Ltd. | Tablet, Orally Disintegrating | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Cardinal Health 110, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Lidl US LLC | Tablet | Oral | 5.8 mg/5.8 mg – 7.5 mg/7.5 mg | 2017 | |
| 
 | |||||
| Dollar General | Lozenge | Oral | 2.8 mg | 2024 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| Cardinal Health 110, Inc. | Pastille | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Cardinal Health 110, Inc. | Pastille | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Melaleuca, Inc. | Lozenge | Oral | 7 mg | 2008 | |
| 
 Indications
 | |||||
| Melaleuca, Inc. | Lozenge | Oral | 7 mg | 2008 | |
| 
 Indications
 | |||||
| Element 26 LLC | Gel | Topical | 100 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Omax Health, Inc | Gel | Topical | 85 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Omax Health, Inc | Gel | Topical | 85 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Omax Health, Inc | Gel | Topical | 85 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Canadian Unique Health Ltd. | Cream | Topical | 12.5 mg/1 g | 2017 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| CVS | Spray | Topical | 16 g/100 g | 2022 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Patch | Topical | 50 mg | 2020 | |
| 
 | |||||
| CVS Pharmacy | Patch | Topical | 50 mg | 2020 | |
| 
 | |||||
| CVS PHARMACY, INC. | Patch | Topical | 750 mg | 2010 | |
| 
 | |||||
| CVS Pharmacy | Liquid | Topical | 16 mg/100 mL | 2021 | |
| 
 Indications
 | |||||
| CVS Pharmacy Inc. | Patch | Topical | 0.05 g/1 g | 2013 | |
| 
 | |||||
| CVS Pharmacy, Inc | Patch | Topical | 5 g/100 g | 2024 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Gel | Topical | 36 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Cream | Topical | 100 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 7.5 mg | 2022 | |
| 
 Indications
 | |||||
| CVS Health | Liquid | Topical | 160 mg/1 mL | 2014 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 5.4 mg | 2022 | |
| 
 Indications
 | |||||
| CVS | Spray | Topical | 10.5 g/100 g | 2022 | |
| 
 Indications
 | |||||
| CVS | Gel | Topical | 4 g/100 g | 2020 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 7.6 mg | 2022 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lotion | Topical | 1 mg/1 mL | 2010 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Cream | Topical | 0.025 g/1 g | 2008 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Gel | Topical | 2 g/100 g | 2014 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Gel | Topical | 20 mg/1 g | 2010 | |
| 
 Indications
 | |||||
| CVS Pharmacy, Inc. | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| CVS Pharmacy | Gel | Topical | 27.5 mg/1 g | 2011 | |
| 
 Indications
 | |||||
| CVS PHARMACY | Gel | Topical | 2.5 g/100 g | 2014 | |
| 
 | |||||
| La Mend, Inc. | Patch | Topical | 5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| LaShe Naturals, LLC | Spray | Topical | 60 mg/1 mL | 2008 | |
| 
 Indications
 | |||||
| LaShe Naturals, LLC | Solution | Topical | 60 mg/1 mL | 2011 | |
| 
 Indications
 | |||||
| Derma Care Research Labs, LLC | Spray | Topical | 16 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Derma Care Research Labs, LLC | Spray | Topical | 10.5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Derma Care Research Labs, LLC | Gel | Topical | 4 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| Derma Care Research Labs, LLC | Liquid | Topical | 16 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Derma Care Research Labs, LLC | Gel | Topical | 2 g/100 g | 2021 | |
| 
 Indications
 | |||||
| DD&D Manufacturing Co. , Ltd | Cream | Topical | 100 mg/1 mL | 2017 | |
| 
 Indications
 | |||||
| doTERRA International, LLC | Stick | Topical | 10 g/100 g | 2022 | |
| 
 Indications
 | |||||
| dōTERRA International, LLC | Stick | Topical | 10 g/100 g | 2021 | |
| 
 Indications
 | |||||
| NFUSE LLC | Emulsion | Topical | 20 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Private Label Beauty and Wellness | Gel | Topical | 2 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Natures Formulae Health Products Ltd. | Ointment | Topical | 12.7 mg/1 g | 2025 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Ointment | Topical | 12.7 mg/1 g | 2025 | |
| 
 | |||||
| Dolgencorp Inc | Liquid | Topical | 160 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Dolgencorp Inc | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Topical | 5.8 mg | 2021 | |
| 
 Indications
 | |||||
| DOLGENCORP INC | Patch | Topical | 750 mg | 2012 | |
| 
 | |||||
| Dolgencorp Inc | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| DOLGENCORP INC | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Dolgencorp, LLC | Gel | Topical | 2 g/100 g | 2010 | |
| 
 Indications
 | |||||
| PURIVITAE, LLC | Gel | Topical | 40 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| PURIVITAE, LLC | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| DISCOUNT DRUG MART | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| DISCOUNT DRUG MART | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| DISCOUNT DRUG MART | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| DISCOUNT DRUG MART | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| Biotanico Inc. | Patch | Topical | 50 mg | 2018 | |
| 
 Indications
 | |||||
| DOCTOR'S CHOICE MEDICAL, LLC | Liquid | Topical | 50 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Dolgencorp, LLC | Patch | Topical | 5 g/100 g | 2023 | |
| 
 Indications
 | |||||
| DOLGENCORP, LLC | Patch | Topical | 5 g | 2017 | |
| 
 Indications
 | |||||
| DOLGENCORP, LLC | Patch | Topical | 5 g/100 g | 2017 | |
| 
 Indications
 | |||||
| DOLGENCORP, LLC | Patch | Topical | 5 g | 2017 | |
| 
 Indications
 | |||||
| Tai Tong Ah Co Pte Ltd | Oil | Topical | 3.5 g/100 mL | 2004 | |
| 
 Indications
 | |||||
| CA-BOTANA INTERNATIONAL | Gel | Topical | 24 g/120 g | 2020 | |
| 
 | |||||
| CA-BOTANA INTERNATIONAL | Gel | Topical | 6 g/120 g | 2020 | |
| 
 | |||||
| DR. KHALILI LLC | Cream | Topical | 6 g/100 g | 2025 | |
| 
 Indications
 | |||||
| DOCTOR PAINE'S MEDICAL, LLC | Cream | Topical | 50 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| Dr. Sabharwal's Wound Care | Patch | Topical | 240 mg | 2024 | |
| 
 Indications
 | |||||
| Great Loong LLC | Patch | Topical | 0.5 g/1 g | 2017 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
| 
 Indications
 | |||||
| Indiana Botanic Gardens | Gel | Topical | 4.58 g/100 g | 2016 | |
| 
 Indications
 | |||||
| Indiana Botanic Gardens | Gel | Topical | 3.89 g/100 g | 2003 | |
| 
 Indications
 | |||||
| Carrasco Enterprises, Inc. | Cream | Topical | 40 mg/1 mL | 2015 | |
| 
 Indications
 | |||||
| LTC Health Corp | Cream | Topical | 2.625 g/75 g | 2009 | |
| 
 Indications
 | |||||
| PDC Brands | Cream | Topical | 100 mg/1 g | 2015 | |
| 
 Indications
 | |||||
| PDC Brands | Gel | Topical | 80 mg/1 g | 2018 | |
| 
 Indications
 | |||||
| Genomma Lab USA | Gel | Topical | 40 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| Genomma Lab USA Inc. | Gel | Topical | 4 g/100 g | 2020 | |
| 
 | |||||
| Ricola Ag | Lozenge | Oral | 8.3 mg | 2011 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 8.5 mg | 2011 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.5 mg | 2011 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2011 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2016 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 8.3 mg | 2011 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2015 | |
| 
 Indications
 | |||||
| Caball Sales, Inc. | Cream | Topical | 1.5 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Caball Sales, Inc. | Spray | Topical | 9 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Eleeo Brands LLC | Stick | Topical | 0.0425 g/4.25 g | 2025 | |
| 
 Indications
 | |||||
| Earthmed LLC | Salve | Topical | 7.9 g/71.9 g | 2025 | |
| 
 Indications
 | |||||
| Proximity Capital Partners LLC dba Asutra | Cream | Topical | 4 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Wicsun Trading | Patch | Topical | 4 g | 2012 | |
| 
 Indications
 | |||||
| Wong’s Pharmaceutical International | Patch | Topical | 4 g | 2012 | |
| 
 Indications
 | |||||
| EMINENCE BIOTECH CORPORATION LIMITED | Spray | Topical | 1000 mg/100 mL | 2013 | |
| 
 Indications
 | |||||
| EMINENCE BIOTECH CORPORATION LIMITED | Spray | Topical | 1700 mg/100 mL | 2013 | |
| 
 Indications
 | |||||
| EMINENCE BIOTECH CORPORATION LIMITED | Spray | Topical | 865.4 mg/50 mL | 2012 | |
| 
 Indications
 | |||||
| Eco Lips, Inc. | Stick | Topical | 0.0425 g/4.25 g | 2023 | |
| 
 Indications
 | |||||
| EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2018 | |
| 
 Indications
 | |||||
| EEZAWAY RELIEF INC | Spray | Topical | 1.25 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.056 g/1 g | 2022 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2019 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Cream | Topical | 2.8 g/56 g | 2019 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Cream | Topical | 2.8 g/56 g | 2019 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Cream | Topical | 2.8 g/56 g | 2019 | |
| 
 Indications
 | |||||
| Eco-Logics, Inc. | Gel | Topical | 35 mg/1 g | 2016 | |
| 
 Indications
 | |||||
| Eco-Logics, Inc. | Gel | Topical | 35 mg/1 g | 2016 | |
| 
 Indications
 | |||||
| Eco-Logics, Inc. | Gel | Topical | 35 mg/1 g | 2016 | |
| 
 Indications
 | |||||
| ACA MANAGEMENT LLC | Cream | Topical | 27.5 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Speer Laboratories LLC | Cream | Topical | 2.4 g/120 g | 2023 | |
| 
 Indications
 | |||||
| Speer Laboratories LLC | Cream | Topical | 2.4 g/120 g | 2023 | |
| 
 Indications
 | |||||
| SUPERVALU INC | Gel | Topical | 2 g/100 g | 2011 | |
| 
 | |||||
| Wal-Mart Stores, Inc. | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Wal-Mart Stores, Inc. | Gel | Topical | 40 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Wal-Mart Stores Inc | Patch | Topical | 50 mg | 2014 | |
| 
 Indications
 | |||||
| Walmart, Inc. | Liquid | Topical | 16 mg/100 mL | 2018 | |
| 
 Indications
 | |||||
| Walmart, Inc. | Liquid | Topical | 16 mg/100 mL | 2020 | |
| 
 Indications
 | |||||
| WalMart | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Walmart | Chewable Gel | Oral | 5 mg | 2024 | |
| 
 Indications
 | |||||
| Walmart | Lozenge | Oral | 5.4 mg | 2024 | |
| 
 Indications
 | |||||
| Wal-Mart Stores Inc | Patch | Topical | 50 mg | 2018 | |
| 
 Indications
 | |||||
| Walmart | Lozenge | Oral | 20 mg | 2024 | |
| 
 Indications
 | |||||
| WalMart | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Prime Enterprises Inc. | Cream | Topical | 12.13 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| Insight Pharmaceuticals | Ointment | Topical | 9.6 mL/60 mL | 2009 | |
| 
 Indications
 | |||||
| Beiersdorf Inc | Lotion | Topical | 0.1 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| Natural Essentials, Inc. | Gel | Topical | 100 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| Natures Sunshine Products, Inc. | Cream | Topical | 1.25 g/100 mL | 2021 | |
| 
 | |||||
| Army & Air Force Exchange Service | Lozenge | Oral | 5.8 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2025 | |
| 
 Indications
 | |||||
| Army & Air Force Exchange Service | Lozenge | Oral | 5.4 mg | 2025 | |
| 
 Indications
 | |||||
| Army & Air Force Exchange Service | Lozenge | Oral | 7.6 mg | 2025 | |
| 
 Indications
 | |||||
| Army & Air Force Exchange Service | Lozenge | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.6 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| BLOOMWELL GARDENS LLC | Cream | Topical | 5 g/100 g | 2025 | |
| 
 Indications
 | |||||
| Walgreen Company | Patch | Topical | 5 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Rite Aid Corporation | Patch | Topical | 5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Cardinal Health, 110 dba LEADER | Patch | Topical | 5 g | 2019 | |
| 
 Indications
 | |||||
| EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| Sagely Enterprises Inc. | Cream | Topical | 10 g/100 g | 2021 | |
| 
 Indications
 | |||||
| United Exchange Corp | Patch | Topical | 750 mg | 2014 | |
| 
 | |||||
| United Exchange Corp | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| United Exchange Corp | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| United Exchange Corp | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| TROY MANUFACTURING, INC | Liquid | Topical | 80 mg/1 mL | 2010 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 8.3 mg | 2013 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2013 | |
| 
 Indications
 | |||||
| BlackPort Distribution | Gel | Topical | 2 g/100 mL | 2017 | |
| 
 Indications
 | |||||
| BlackPort Distribution | Gel | Topical | 4 g/100 mL | 2017 | |
| 
 Indications
 | |||||
| CunningPac | Gel | Topical | 2 g/100 mL | 2017 | |
| 
 Indications
 | |||||
| United Exchange Corp. | Gel | Topical | 25 mg/1 g | 2019 | |
| 
 | |||||
| United Exchange Corporation | Stick | Topical | 20 mg/1 g | 2018 | |
| 
 | |||||
| FAMILY DOLLAR | Patch | Topical | 750 mg | 2012 | |
| 
 | |||||
| Family Dollar Services, Inc. | Patch | Topical | 50 mg | 2019 | |
| 
 | |||||
| Family Dollar | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| Natural Essentials Inc. | Gel | Topical | 35 mg/1 g | 2013 | |
| 
 Indications
 | |||||
| Natural Essentials Inc. | Spray | Topical | 100 mg/1 mL | 2013 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Gel | Topical | 33 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Natural Essentials, Inc. | Spray | Topical | 89 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| THE FEEL GOOD LAB, LLC | Cream | Topical | 12.5 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| The Feel Good Lab | Lotion | Topical | 12.5 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| The Feel Good Lab | Lotion | Topical | 12.5 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| THE FEEL GOOD LAB, LLC | Lotion | Topical | 12.5 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| The Feel Good Lab, LLC | Cream | Topical | 12.5 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| BeYou Together Ltd | Patch | Topical | 10 mg | 2025 | |
| 
 Indications
 | |||||
| Unexo Life Sciences Private Limited | Patch | Topical | 100 mg | 2024 | |
| 
 Indications
 | |||||
| Unexo Life Sciences, Private Limited | Patch | Topical | 200 mg | 2019 | |
| 
 Indications
 | |||||
| FISICO INC. | Cream | Topical | 50 mg/1 g | 2022 | |
| 
 Indications
 | |||||
| Symedic LLC | Spray | Topical | 2.25 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| SOLVADERM LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
| 
 Indications
 | |||||
| Derma Care Research Labs, LLC | Cream | Topical | 1.25 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| PRINCE OF PEACE ENTERPRISES INC. | Granule, for Solution | Oral | 270 mg/6 g | 2010 | |
| 
 Indications
 | |||||
| Catalysis, SL | Cream | Topical | 1.25 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Smith Amish, LLC | Cream | Topical | 1.25 g/100 g | 2024 | |
| 
 Indications
 | |||||
| New Avon LLC | Lotion | Topical | 13.5 mg/1 mL | 2012 | |
| 
 Indications
 | |||||
| Donegal Bay Ltd | Cream | Topical | 0.1 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Oil | Topical | 24 mg/1 mL | 2016 | |
| 
 | |||||
| WISE CONSUMER PRODUCTS CO. | Oil | Topical | 20 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Wise Consumer Products | Lotion | Topical | 1.3 g/100 g | 2024 | |
| 
 Indications
 | |||||
| WISE CONSUMER PRODUCTS CO. | Oil | Topical | 20 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Wise Consumer Products | Lotion | Topical | 1.3 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Walgreen Co. | Gel | Topical | 36 mg/1 mL | 2025 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Riclan S. A. | Lozenge | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Riclan S. A. | Lozenge | Oral | 5.4 mg | 2022 | |
| 
 Indications
 | |||||
| Riclan S. A. | Lozenge | Oral | 7.5 mg | 2022 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Riclan S. A. | Lozenge | Oral | 2.7 mg | 2022 | |
| 
 Indications
 | |||||
| R. L. ALBERT & SON, INC | Suspension/ Drops | Oral | 2.7 mg | 2022 | |
| 
 Indications
 | |||||
| Shandong Vianor Healthy Science Co. , Ltd. | Gel | Topical | 4 g/100 mL | 2020 | |
| 
 | |||||
| LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 g | 2025 | |
| 
 Indications
 | |||||
| LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| Natural Essentials Inc. | Liquid | Topical | 37 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| GASPARI ANTI-AGING LLC | Cream | Topical | 20 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Consumer Product Partners, LLC | Gel | Topical | 40 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Kroger | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Meijer Distribution | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Topco | Gel | Topical | 40 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Riclan S. A. | Lozenge | Oral | 9 mg | 2021 | |
| 
 Indications
 | |||||
| Riclan S. A. | Lozenge | Oral | 8.4 mg | 2021 | |
| 
 Indications
 | |||||
| Riclan S. A. | Lozenge | Oral | 7 mg | 2021 | |
| 
 Indications
 | |||||
| Geri-Gentle Corporation | Patch | Topical | 50 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Geri-Gentle Corporation | Patch | Topical | 50 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Germa Products, LLC | Ointment | Topical | 10 mg/1 mL | 2019 | |
| 
 | |||||
| Germa Products, LLC | Ointment | Topical | 18 mg/1 mL | 2019 | |
| 
 | |||||
| Chattem, Inc. | Lotion | Topical | 0.005 g/1 g | 2016 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Powder | Topical | 0.8 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Powder | Topical | 1 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Powder | Topical | 0.15 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Eden's Answers, Inc. | Cream | Topical | 62.5 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Amerisource Bergen | Patch | Topical | 5 g/100 g | 2023 | |
| 
 Indications
 | |||||
| AmerisourceBergen Drug Corporation | Gel | Topical | 2 g/100 g | 1988 | |
| 
 Indications
 | |||||
| Amerisource Bergen | Gel | Topical | 4 g/1 mL | 2025 | |
| 
 Indications
 | |||||
| Geiss, Destin, Dunn | Lozenge | Oral | 5.8 mg | 2021 | |
| 
 Indications
 | |||||
| Geiss, Destin, Dunn | Lozenge | Oral | 7.5 mg | 2021 | |
| 
 Indications
 | |||||
| GOOD SENSE | Patch | Topical | 5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Geiss, Destin, Dunn | Lozenge | Oral | 7.6 mg | 2022 | |
| 
 Indications
 | |||||
| Geiss, Destin & Dunn, Inc | Gel | Topical | 4 g/100 mL | 2025 | |
| 
 | |||||
| Geiss, Destin and Dunn, Inc. | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Geiss, Destin and Dunn, Inc. | Patch | Topical | 50 mg | 2018 | |
| 
 | |||||
| Geiss, Destin, Dunn | Lozenge | Oral | 5.4 mg | 2021 | |
| 
 Indications
 | |||||
| PHYTOPIA CO. , LTD. | Oil | Topical | 20 mg/500 mg | 2016 | |
| 
 | |||||
| Green Compass, Inc. | Gel | Topical | 5 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| Green Compass, Inc. | Liquid | Topical | 5 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| SUNSET NOVELTIES, INC | Gel | Topical | 4 g/100 g | 2020 | |
| 
 Indications
 | |||||
| SUNSET NOVELTIES, INC | Stick | Topical | 10 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| Unifirst First Aid Corporation | Lozenge | Oral | 7.6 mg | 2011 | |
| 
 Indications
 | |||||
| Unifirst First Aid Corporation | Lozenge | Oral | 8.6 mg | 2019 | |
| 
 Indications
 | |||||
| GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD | Plaster | Transdermal | 35 mg | 2022 | |
| 
 Indications
 | |||||
| Guangzhou Yilong Cosmetics Co. , Ltd | Granule | Topical | 1.45 g/100 g | 2024 | |
| 
 | |||||
| Davion, Inc | Powder | Topical | 1 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 5.4 mg | 2025 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2024 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 8.8 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2025 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 7.6 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 5.8 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2020 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 5.8 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 3.2 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 1.8 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.7 mg | 2020 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 7.5 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 6.8 mg | 2016 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 5.8 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2021 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.7 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 2.9 mg | 2020 | |
| 
 Indications
 | |||||
| Mondelez Global LLC | Lozenge | Oral | 5.4 mg | 2019 | |
| 
 Indications
 | |||||
| Mondelēz Global LLC | Lozenge | Oral | 6.4 mg | 2025 | |
| 
 Indications
 | |||||
| Mondelēz Global LLC | Lozenge | Oral | 6.4 mg | 2019 | |
| 
 Indications
 | |||||
| PRINCE OF PEACE ENTERPRISES INC. | Syrup | Oral | 0.1 g/100 mL | 2014 | |
| 
 Indications
 | |||||
| Globalworkscompany. Co. , Ltd. | Gel | Topical | 2.0 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| PALM ORTHOPEDICS & INTERVENTIONAL PAIN LLC | Gel | Topical | 30 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Carolina Cannabis Creations LLC | Salve | Topical | 1.4 g/111.45 g | 2023 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Cream | Topical | 2.18 g/112 g | 2024 | |
| 
 Indications
 | |||||
| Renu Laboratories, LLC | Cream | Topical | 8.74 g/448 g | 2024 | |
| 
 Indications
 | |||||
| McKesson | Patch | Topical | 428.5 mg | 2017 | |
| 
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Powder | Topical | 0.8 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Powder | Topical | 1 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Powder | Topical | 0.15 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 10 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Liquid | Topical | 4 g/1 mL | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Liquid | Topical | 0.16 g/1 mL | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g | 2025 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Spray | Topical | 10.5 mg/1 mL | 2025 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Gel | Topical | 0.6 g/1 mL | 2025 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Gel | Topical | 4 g/1 mL | 2022 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 5.8 mg | 2021 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 7.5 mg | 2021 | |
| 
 Indications
 | |||||
| Davion, Inc | Powder | Topical | 0.15 g/100 g | 2018 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 5.4 mg | 2021 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 7.6 mg | 2021 | |
| 
 Indications
 | |||||
| Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 0.04 g/1 mL | 2025 | |
| 
 Indications
 | |||||
| The Anthos Group | Spray | Topical | 10.5 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| Clientele, Inc. | Cream | Topical | 2 mg/100 mL | 2019 | |
| 
 Indications
 | |||||
| Pedicis Research, LLC | Cream | Topical | 50 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| Telebrands Corp | Gel | Topical | 8 mg/100 mL | 2019 | |
| 
 Indications
 | |||||
| Telebrands Corp | Patch | Topical | 5 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Telebrands Corp | Gel | Topical | 8 mg/100 mL | 2020 | |
| 
 Indications
 | |||||
| Telebrands Corp | Gel | Topical | 8 mg/100 mL | 2025 | |
| 
 Indications
 | |||||
| Telebrands Corp | Gel | Topical | 8 g/8 g | 2024 | |
| 
 Indications
 | |||||
| Balassa Laboratories Inc. | Stick | Topical | 0.1 g/1 g | 2021 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 4.8 mg | 2016 | |
| 
 Indications
 | |||||
| Meijer, Inc. | Pastille | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| Walmart | Lozenge | Oral | 4.8 mg | 2018 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| WHOLE FOODS MARKET, INC. | Pastille | Oral | 4.8 mg | 2024 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Spray | Topical | 0.06 g/1 g | 2023 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Liquid | Topical | 4.2 g/84 g | 2020 | |
| 
 Indications
 | |||||
| Meijer, Inc. | Pastille | Oral | 1.1 mg | 2025 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 1.1 mg | 2025 | |
| 
 Indications
 | |||||
| Bordoloi Biotech, LLC. | Cream | Topical | 70 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| Menper Distributors, Inc. | Gel | Topical | 1 g/100 g | 2012 | |
| 
 Indications
 | |||||
| SIBORG LLC | Cream | Topical | 12.5 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Walmart | Lozenge | Oral | 2.7 mg | 2018 | |
| 
 Indications
 | |||||
| BestCo Inc. | Lozenge | Oral | 7.5 mg | 2015 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 7.5 mg | 2013 | |
| 
 Indications
 | |||||
| Rite Aid | Lozenge | Oral | 7.5 mg | 2013 | |
| 
 Indications
 | |||||
| Rite Aid | Lozenge | Oral | 7.5 mg | 2015 | |
| 
 Indications
 | |||||
| The Kroger Co. | Lozenge | Oral | 7.5 mg | 2014 | |
| 
 Indications
 | |||||
| The Kroger Co. | Lozenge | Oral | 7.5 mg | 2014 | |
| 
 Indications
 | |||||
| The Kroger Co. | Lozenge | Oral | 7.5 mg | 2014 | |
| 
 Indications
 | |||||
| Walgreen Co. | Lozenge | Oral | 7.5 mg | 2016 | |
| 
 Indications
 | |||||
| Walgreens Co, | Lozenge | Oral | 7.5 mg | 2016 | |
| 
 Indications
 | |||||
| 7-Eleven Inc. | Lozenge | Oral | 7.5 mg | 2015 | |
| 
 Indications
 | |||||
| American Sales | Lozenge | Oral | 7.5 mg | 2016 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| Big Lots | Lozenge | Oral | 7.5 mg | 2017 | |
| 
 Indications
 | |||||
| Boston Nutraceutical Production SL | Pastille | Oral | 7.6 mg | 2019 | |
| 
 Indications
 | |||||
| Boston Nutraceutical Production SL | Pastille | Oral | 7.6 mg | 2019 | |
| 
 Indications
 | |||||
| Boston Nutraceutical Production SL | Pastille | Oral | 7.6 mg | 2019 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association | Lozenge | Oral | 7.5 mg | 2017 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 7.5 mg | 2015 | |
| 
 Indications
 | |||||
| Discount Drug Mart | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 7.5 mg | 2016 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 7.5 mg | 2016 | |
| 
 Indications
 | |||||
| Family Dollar | Lozenge | Oral | 7.5 mg | 2013 | |
| 
 Indications
 | |||||
| Family Dollar | Lozenge | Oral | 7.5 mg | 2013 | |
| 
 Indications
 | |||||
| Harris Teeter | Lozenge | Oral | 7.5 mg | 2017 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 7.5 mg | 2017 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 7.5 mg | 2017 | |
| 
 Indications
 | |||||
| Publix | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| Safeway | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 7.5 mg | 2013 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 7.5 mg | 2013 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 7.5 mg | 2013 | |
| 
 Indications
 | |||||
| Trader Joe's Company | Lozenge | Oral | 6 mg | 2018 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. dba UNFI | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. dba UNFI | Lozenge | Oral | 7.5 mg | 2018 | |
| 
 Indications
 | |||||
| Valu Merchandisers | Lozenge | Oral | 7.5 mg | 2017 | |
| 
 Indications
 | |||||
| Walmart Stores Inc. | Lozenge | Oral | 7.5 mg | 2016 | |
| 
 Indications
 | |||||
| Whole Foods | Lozenge | Oral | 7.5 mg | 2020 | |
| 
 Indications
 | |||||
| Winco foods | Lozenge | Oral | 7.5 mg | 2016 | |
| 
 Indications
 | |||||
| Winco Foods | Lozenge | Oral | 7.5 mg | 2014 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2024 | |
| 
 Indications
 | |||||
| WHOLE FOODS MARKET, INC. | Pastille | Oral | 7.5 mg | 2024 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Island Abbey Foods Ltd. | Lozenge | Oral | 8.6 mg/2.5 g | 2012 | |
| 
 | |||||
| Chain Drug Consortium, LLC | Patch | Topical | 5 g/100 g | 2017 | |
| 
 Indications
 | |||||
| Harris Teeter | Patch | Topical | 5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Walgreen Company | Patch | Topical | 5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Henan Enokon Medical Instrument Co. , Ltd. | Patch | Topical | 5 g/100 1 | 2024 | |
| 
 Indications
 | |||||
| Dynarex | Patch | Topical | 285 mg/5700 mg | 2019 | |
| 
 Indications
 | |||||
| Humco Holding Group, Inc | Liquid | Topical | 16 mg/100 mL | 2018 | |
| 
 Indications
 | |||||
| Humphreys Pharmacal, Incorporated | Liquid | Topical | 12.5 mg/1 mL | 1972 | |
| 
 Indications
 | |||||
| Filo America | Gel | Topical | 1.0 g/100 g | 2015 | |
| 
 Indications
 | |||||
| China Ningbo Shangge Cosmetic Technology Corp. | Gel | Topical | 1 g/100 g | 2015 | |
| 
 | |||||
| North & South Wholesalers LLC | Gel | Topical | 1.25 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Personal Care Products | Gel | Topical | 2.27 g/227 g | 2011 | |
| 
 Indications
 | |||||
| Volume Distributors, Inc. | Gel | Topical | 1 g/100 g | 2015 | |
| 
 | |||||
| China Ningbo Shangge Cosmetic Technology Corp. | Gel | Topical | 2.84 mg/227 mg | 2013 | |
| 
 | |||||
| Greenbrier International, Inc. | Gel | Topical | 2.84 mg/227 mg | 2013 | |
| 
 | |||||
| Southern Sales & Service, Inc. | Gel | Topical | 0.02 g/1 g | 2015 | |
| 
 Indications
 | |||||
| Gadal Laboratories Inc | Gel | Topical | 2 g/100 g | 2013 | |
| 
 Indications
 | |||||
| Gadal Laboratories, Inc. | Gel | Topical | 16.95 g/113 g | 2012 | |
| 
 Indications
 | |||||
| Southern Sales & Service, Inc. | Gel | Topical | 0.15 g/1 g | 2015 | |
| 
 Indications
 | |||||
| Southern Sales & Service, Inc. | Gel | Topical | 0.02 g/1 g | 2017 | |
| 
 Indications
 | |||||
| Southern Sales & Service, Inc. | Patch | Topical | 5 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Southern Sales & Service, Inc. | Cloth | Topical | 50 mg/1 g | 2022 | |
| 
 Indications
 | |||||
| C. D. M. A. Inc. | Gel | Topical | 55 mg/1 mL | 2013 | |
| 
 Indications
 | |||||
| C. D. M. A. Inc. | Gel | Topical | 55 mg/1 mL | 2013 | |
| 
 Indications
 | |||||
| Natural Essentials, Inc. | Spray | Topical | 100 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Gel | Topical | 35 mg/1 mL | 2017 | |
| 
 Indications
 | |||||
| Nichiban Company Limited | Patch | Topical | 787.5–866.25 mg | 2009 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Spray | Topical | 16 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Liquid | Topical | 4 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Liquid | Topical | 0.16 g/1 mL | 2009 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Liquid | Topical | 8 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| Chattem, Inc. | Gel | Topical | 0.025 g/1 g | 2007 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2021 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Liquid | Topical | 4.2 g/84 g | 2021 | |
| 
 Indications
 | |||||
| Adaptive Health, LLC | Cream | Topical | 12.5 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| Healthy Directions, LLC | Cream | Topical | 12.5 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| Healthy Directions, LLC | Liquid | Topical | 12.5 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| WYNNPHARM INC. | Gel | Topical | 30 mg/1 g | 2022 | |
| 
 Indications
 | |||||
| Excel Health, Inc | Gel | Topical | 60 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| JACK BLACK LLC | Cream | Topical | 2.2 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Jakemans (Confectioners) Limited | Lozenge | Oral | 5 mg | 2011 | |
| 
 | |||||
| Jakemans (Confectioners) Limited | Lozenge | Oral | 5 mg | 2011 | |
| 
 Indications
 | |||||
| Jakemans (Confectioners) Limited | Lozenge | Oral | 5 mg | 2011 | |
| 
 Indications
 | |||||
| Jakemans (Confectioners) Ltd. | Lozenge | Oral | 5 mg | 2013 | |
| 
 Indications
 | |||||
| BioZone Laboratories, Inc. | Cream | Topical | 50 mg/1 g | 2009 | |
| 
 Indications
 | |||||
| Shaklee Corporation | Cream | Topical | 50 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| Allure Labs | Cream | Topical | 1.5 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Smith Amish, LLC | Cream | Topical | 1.25 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Lifeline Naturals of America, Inc. | Ointment | Topical | 16 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| Joy Organics Llc | Cream | Topical | 4 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Liquid | Topical | 1.4 g/28 g | 2021 | |
| 
 Indications
 | |||||
| Just Brands LLC | Gel | Topical | 4 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Liquid | Topical | 1.4 g/28 g | 2021 | |
| 
 Indications
 | |||||
| K19 LLC | Liquid | Topical | 12.5 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| The Podiatree Co | Liquid | Topical | 10 g/100 mL | 2014 | |
| 
 Indications
 | |||||
| The Podiatree Co | Liquid | Topical | 10 g/100 mL | 2014 | |
| 
 Indications
 | |||||
| SUNSET NOVELTIES, INC | Gel | Topical | 4 g/100 g | 2022 | |
| 
 Indications
 | |||||
| CA-BOTANA INTERNATIONAL | Gel | Topical | 6 g/120 g | 2020 | |
| 
 | |||||
| Eezaway Relief Inc | Liquid | Topical | 2.75 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Avlon Industries, Inc. | Gel | Topical | 10 mg/1 g | 2014 | |
| 
 Indications
 | |||||
| No Reason, LLC | Cream | Topical | 100 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Fuzhou Ayimong Trading Co. , Ltd. | Patch | Topical | 40 g/100 1 | 2023 | |
| 
 Indications
 | |||||
| Pharmadel LLC | Ointment | Topical | 1.25 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Dee Cee Laboratories, Inc. | Gel | Topical | 2.5 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Kroger | Lozenge | Oral | 5.8 mg | 2020 | |
| 
 Indications
 | |||||
| Kroger Company | Patch | Topical | 5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Kroger | Lozenge | Oral | 5.4 mg | 2020 | |
| 
 Indications
 | |||||
| Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| KT Health LLC | Cream | Topical | 2 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Henan Lingrui Pharmaceutical Co Ltd | Plaster | Transdermal | 3.0 g/100 g | 2010 | |
| 
 Indications
 | |||||
| PHYTOPIA CO. , LTD. | Oil | Topical | 0.8 mg/50 mL | 2016 | |
| 
 | |||||
| PHYTOPIA CO. , LTD. | Oil | Topical | 0.8 mg/50 mL | 2016 | |
| 
 | |||||
| LactiGo, Inc. | Gel | Topical | 12.5 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Jiangsu Chaben Medical Healthcare Technology Co. , Ltd | Gel | Topical | 0.04 g/1 g | 2022 | |
| 
 Indications
 | |||||
| Jiangsu Chaben Medical Healthcare Technology Co. , Ltd | Gel | Topical | 0.04 g/1 g | 2022 | |
| 
 Indications
 | |||||
| Jiangsu Chaben Medical Healthcare Technology Co. , Ltd | Patch | Topical | 0.05 g/1 g | 2022 | |
| 
 Indications
 | |||||
| Lansinoh Laboratories Inc | Cream | Topical | 0.5 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Young Living Essential Oils, LC | Spray | Topical | 0.005 g/1 g | 2017 | |
| 
 Indications
 | |||||
| Cardinal Health, 110 dba LEADER | Gel | Topical | 40 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Cardinal Health 110, LLC. DBA Leader | Lozenge | Oral | 2.5 mg | 2024 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2024 | |
| 
 Indications
 | |||||
| Cardinal Health, 110 dba LEADER | Gel | Topical | 20 mg/1 g | 2017 | |
| 
 Indications
 | |||||
| Cardinal Health, 110 dba LEADER | Gel | Topical | 40 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Target Corporation Inc. | Pastille | Oral | 1.1 mg | 2024 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 1.1 mg | 2023 | |
| 
 Indications
 | |||||
| Clinical Resolution Laboratory, Inc. | Cream | Topical | 40 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| Ebanel Laboratories, Inc | Cream | Topical | 40 mg/1 g | 2025 | |
| 
 Indications
 | |||||
| Lilas Wellness, Inc. | Patch | Topical | 200 mg | 2019 | |
| 
 Indications
 | |||||
| Lilas Wellness, Inc. | Patch | Topical | 200 mg | 2025 | |
| 
 Indications
 | |||||
| Dengfeng City Jucai Trading Co. , LTD | Patch | Topical | 4 g/100 1 | 2023 | |
| 
 | |||||
| Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Powder | Topical | 2 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Ozeion LLC | Gel | Topical | 0.24 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Cosmetic Specialty Labs, Inc. | Cream | Topical | 4 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| Pacific Health Collabroative | Gel | Topical | 2.5 g/100 g | 2013 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, LLC | Cream | Topical | 22.7 g/454 g | 2019 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, LLC | Liquid | Topical | 4.2 g/84 g | 2025 | |
| 
 | |||||
| RENU LABORATORIES, LLC | Cream | Topical | 5.6 g/112 g | 2019 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2018 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2019 | |
| 
 Indications
 | |||||
| Ubu/Elements, Inc. | Cream | Topical | 5 g/100 mL | 2023 | |
| 
 | |||||
| Ubu/Elements, Inc. | Spray | Topical | 118 g/100 mL | 2023 | |
| 
 | |||||
| Ubu/Elements, Inc. | Cream | Topical | 5 g/100 mL | 2023 | |
| 
 | |||||
| Ubu/Elements, Inc. | Liquid | Topical | 5 g/100 mL | 2019 | |
| 
 | |||||
| Cherry Hill Sales Co | Gel | Topical | 2.5 g/100 g | 2014 | |
| 
 Indications
 | |||||
| Cosmetic Specialty labs, Inc. | Lotion | Topical | 3 g/100 g | 2013 | |
| 
 Indications
 | |||||
| 53942 | Lozenge | Oral | 5.8 mg | 2021 | |
| 
 Indications
 | |||||
| DeMoulas | Lozenge | Oral | 7.5 mg | 2021 | |
| 
 Indications
 | |||||
| DeMoulas | Lozenge | Oral | 5.4 mg | 2021 | |
| 
 Indications
 | |||||
| Davion, Inc | Powder | Topical | 1 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Walmart Stores Inc | Powder | Topical | 0.1 g/1 g | 2020 | |
| 
 Indications
 | |||||
| L'Oreal USA Products Inc | Lipstick | Topical | 5 mg/1 g | 2013 | |
| 
 Indications
 | |||||
| L'Oreal USA Products Inc | Lipstick | Topical | 5 mg/1 g | 2016 | |
| 
 Indications
 | |||||
| McKesson Medical-Surgical | Lozenge | Oral | 7.6 mg | 2022 | |
| 
 Indications
 | |||||
| McKesson Medical-Surgical | Lozenge | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| SKIN SHERPA NORTH AMERICA LLC | Gel | Topical | 40 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| MEDKO LLC | Liquid | Topical | 120 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Unifirst First Aid Corporation | Lozenge | Oral | 7.6 mg | 2008 | |
| 
 Indications
 | |||||
| Unifirst First Aid Corporation | Lozenge | Oral | 8.6 mg | 2019 | |
| 
 Indications
 | |||||
| Straight Arrow Products, Inc. | Gel | Topical | .07 g/1 g | 2004 | |
| 
 Indications
 | |||||
| Walmart Stores Inc | Powder | Topical | 0.42 g/283 g | 2020 | |
| 
 Indications
 | |||||
| Walmart Stores Inc | Powder | Topical | 2.26 g/283 g | 2020 | |
| 
 Indications
 | |||||
| Earth Mama Angel Baby LLC | Stick | Topical | 0.0425 g/4.25 g | 2024 | |
| 
 Indications
 | |||||
| Burt's Bees, Inc. | Stick | Topical | 0.9 g/100 g | 2016 | |
| 
 Indications
 | |||||
| American Sales Company | Patch | Topical | 428.5 mg | 2011 | |
| 
 Indications
 | |||||
| Kareway Product, Inc. | Patch | Topical | 428.5 mg | 2011 | |
| 
 Indications
 | |||||
| Kareway Product, Inc. | Patch | Topical | 400 mg | 2011 | |
| 
 Indications
 | |||||
| Unifirst First Aid Corporation | Lozenge | Oral | 5.8 mg | 2011 | |
| 
 Indications
 | |||||
| FARLA MEDICAL HEALTHCARE LTD | Patch | Topical | 5 g | 2020 | |
| 
 Indications
 | |||||
| SHIELD LINE LLC | Gel | Topical | 4.54 g/227 g | 2019 | |
| 
 Indications
 | |||||
| Respect Manufacturing Corporation | Cream | Topical | 2.012 g/50.3 g | 2020 | |
| 
 Indications
 | |||||
| Respect Manufacturing Corporation | Cream | Topical | 2.012 g/50.3 g | 2020 | |
| 
 Indications
 | |||||
| Respect Manufacturing Corporation | Cream | Topical | 2.36 g/59.1 g | 2022 | |
| 
 Indications
 | |||||
| Meijer | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Meijer | Spray | Topical | 16 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Meijer Distribution, Inc. | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Sklar BOV Solutions Inc | Spray | Topical | 105 mg/1 g | 2020 | |
| 
 | |||||
| MEIJER DISTRIBUTION, INC | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Meijer Inc | Patch | Topical | 5 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Meijer Inc. | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Meijer | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Meijer Distribution Inc | Patch | Topical | 5 g | 2017 | |
| 
 Indications
 | |||||
| Meijer Distribution, INC | Liquid | Topical | 160 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Sklar BOV Solutions Inc | Spray | Topical | 160 mg/1 g | 2020 | |
| 
 | |||||
| Meijer Distribution | Powder | Topical | 1 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Meijer | Spray | Topical | 10.5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| MEIJER DISTRIBUTION, INC | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 20 mg | 2024 | |
| 
 Indications
 | |||||
| Meijer Distribution Inc | Patch | Topical | 5 g | 2017 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 2.7 mg | 2024 | |
| 
 Indications
 | |||||
| PHYTOPIA CO. , LTD. | Oil | Topical | 6 mg/50 mL | 2016 | |
| 
 | |||||
| THE EGYPTIAN SAUDI CO FOR MEDICAL MANUFACTURING MASCOMID | Patch | Topical | 15 mg/1 g | 2018 | |
| 
 | |||||
| Alexso, Inc | Cream | Topical | 40 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| Amish Origins LLC | Cream | Topical | 8 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Amish Origins LLC | Cream | Topical | 8 g/100 g | 2013 | |
| 
 Indications
 | |||||
| FlexiGo Inc | Paste | Topical | 0.01 g/100 mL | 2025 | |
| 
 | |||||
| FSA Store Inc. | Powder | Topical | 10 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| McKesson | Lozenge | Oral | 0.7 g/1 g | 2020 | |
| 
 Indications
 | |||||
| McKesson | Lozenge | Oral | 0.86 g/1 g | 2020 | |
| 
 Indications
 | |||||
| Relief-Mart, Inc | Spray | Topical | 2 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| SUNSET PAIN RELIEF ROLL-ON 3OZ | Gel | Topical | 4 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| Target Corporation | Powder | Topical | 10 mg/1 g | 2025 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Powder | Topical | 2.8 g/283 g | 2019 | |
| 
 Indications
 | |||||
| Unexo Life Sciences Private Limited | Patch | Topical | 105 mg | 2022 | |
| 
 Indications
 | |||||
| VALU MERCHANDISERS, CO | Powder | Topical | 2.8 g/283 g | 2019 | |
| 
 Indications
 | |||||
| Unexo Life Sciences, Private Limited | Patch | Topical | 440 mg | 2018 | |
| 
 Indications
 | |||||
| Unexo Life Sciences, Private Limited | Patch | Topical | 600 mg | 2020 | |
| 
 Indications
 | |||||
| Unexo Life Sciences, Private Limited | Patch | Topical | 910 mg | 2020 | |
| 
 Indications
 | |||||
| Cardinal Health | Lozenge | Oral | 5.4 mg | 2017 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association | Lozenge | Oral | 5.4 mg | 2017 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 5.4 mg | 2013 | |
| 
 Indications
 | |||||
| Rite Aid | Lozenge | Oral | 5.4 mg | 2015 | |
| 
 Indications
 | |||||
| Safeway Inc. | Lozenge | Oral | 5.4 mg | 2014 | |
| 
 Indications
 | |||||
| The Kroger Co. | Lozenge | Oral | 5.4 mg | 2014 | |
| 
 Indications
 | |||||
| Walgreens | Lozenge | Oral | 5.4 mg | 2016 | |
| 
 Indications
 | |||||
| 7-Eleven Inc. | Lozenge | Oral | 5.4 mg | 2016 | |
| 
 Indications
 | |||||
| American Sales | Lozenge | Oral | 5.4 mg | 2016 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 5.4 mg | 2018 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 5.4 mg | 2018 | |
| 
 Indications
 | |||||
| Big Lots | Lozenge | Oral | 5.4 mg | 2017 | |
| 
 Indications
 | |||||
| Boston Nutraceutical Production SL | Pastille | Oral | 5.8 mg | 2019 | |
| 
 Indications
 | |||||
| Boston Nutraceutical Production SL | Pastille | Oral | 5.8 mg | 2019 | |
| 
 Indications
 | |||||
| BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 5.4 mg | 2022 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 5.4 mg | 2015 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2016 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2016 | |
| 
 Indications
 | |||||
| Family Dollar | Lozenge | Oral | 5.4 mg | 2013 | |
| 
 Indications
 | |||||
| Family Dollar | Lozenge | Oral | 5.4 mg | 2013 | |
| 
 Indications
 | |||||
| Harris Teeter | Lozenge | Oral | 5.4 mg | 2017 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 5.4 mg | 2017 | |
| 
 Indications
 | |||||
| Meijer Distribution Inc. | Lozenge | Oral | 5.4 mg | 2014 | |
| 
 Indications
 | |||||
| Publix | Lozenge | Oral | 5.4 mg | 2018 | |
| 
 Indications
 | |||||
| Rite Aid Corporation | Lozenge | Oral | 5.4 mg | 2013 | |
| 
 Indications
 | |||||
| Target Corporation Inc. | Pastille | Oral | 5.8 mg | 2024 | |
| 
 Indications
 | |||||
| Target Corporation Inc. | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Target Corporation Inc. | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 5.4 mg | 2013 | |
| 
 Indications
 | |||||
| Valu Merchandisers | Lozenge | Oral | 5.4 mg | 2017 | |
| 
 Indications
 | |||||
| WHOLE FOODS MARKET, INC. | Pastille | Oral | 5.8 mg | 2024 | |
| 
 Indications
 | |||||
| Winco Foods | Lozenge | Oral | 5.4 mg | 2014 | |
| 
 Indications
 | |||||
| Winco Foods | Lozenge | Oral | 5.4 mg | 2016 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 7.6 mg | 2025 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 7.5 mg | 2025 | |
| 
 Indications
 | |||||
| 7-ELEVEN | Lozenge | Oral | 2.5 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2024 | |
| 
 Indications
 | |||||
| Genia Care Phamaceutical S. A. | Ointment | Topical | 50 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 20 mg | 2023 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 20 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2024 | |
| 
 Indications
 | |||||
| Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Patch | Topical | 0.04 g/1 g | 2024 | |
| 
 Indications
 | |||||
| Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2023 | |
| 
 Indications
 | |||||
| Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2024 | |
| 
 Indications
 | |||||
| Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2023 | |
| 
 Indications
 | |||||
| Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2023 | |
| 
 Indications
 | |||||
| Guangzhou Hanhai Trading Co. , Ltd | Patch | Topical | 19 g/100 1 | 2023 | |
| 
 | |||||
| Medhome Pharma Inc | Liquid, Extended Release | Topical | 0.04 g/1 mL | 2024 | |
| 
 | |||||
| BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 20 mg | 2020 | |
| 
 Indications
 | |||||
| Cloud 9 Naturally | Lotion | Topical | 1.3 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 2.5 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Tablet, Chewable, Extended Release | Oral | 2.7 mg/2850 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Tablet, Chewable, Extended Release | Oral | 2.7 mg/2850 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg/2850 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg/2850 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| Medical Group Care LLC | Lozenge | Oral | 2 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 4.8 mg | 2025 | |
| 
 Indications
 | |||||
| Functional Energetic, Inc. | Cream | Topical | 15 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Crown Laboratories | Gel | Topical | 20 mg/1 g | 2011 | |
| 
 Indications
 | |||||
| Winning Solutions | Cream | Topical | 0.028 g/28 g | 2011 | |
| 
 Indications
 | |||||
| Winning Solutions | Cream | Topical | 0.224 g/224 g | 2011 | |
| 
 Indications
 | |||||
| Winning Solutions | Cream | Topical | 0.224 g/224 g | 2011 | |
| 
 Indications
 | |||||
| Winning Solutions | Liquid | Topical | 1.8 mL/90 mL | 2006 | |
| 
 Indications
 | |||||
| Cosmetic Specialty labs, Inc. | Cream | Topical | 3 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Southern Sales & Services, Inc | Gel | Topical | 2 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Biological Health Group Corporation | Cream | Topical | 1.5 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| Avon Products, Inc. | Spray | Topical | 5 mg/1 mL | 2012 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 4.8 mg | 2015 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 4.8 mg | 2015 | |
| 
 Indications
 | |||||
| Mountainside Medical Equipment, Inc. | Gel | Topical | 5 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| Mountainside Medical Equipment, Inc. | Gel | Topical | 6 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| Dudley Wellness Company Inc | Cream | Topical | 2.5 g/100 g | 2013 | |
| 
 Indications
 | |||||
| DUDLEY WELLNESS COMPANY INC | Cream | Topical | 2.5 g/100 g | 2013 | |
| 
 Indications
 | |||||
| Jiangxi Hemei Pharmaceutical Co. , Ltd | Cream | Topical | 1 g/100 g | 2025 | |
| 
 Indications
 | |||||
| WATER-JEL TECHNOLOGIES | Gel | Topical | 3.5 g/100 mL | 2010 | |
| 
 Indications
 | |||||
| Discount Drug Mart, Inc. | Gel | Topical | 2.5 g/100 g | 2015 | |
| 
 Indications
 | |||||
| Kareway Product, Inc. | Gel | Topical | 2.5 g/100 g | 2013 | |
| 
 Indications
 | |||||
| Navarro Discount Pharmacies, LLC | Gel | Topical | 2.5 g/100 g | 2012 | |
| 
 Indications
 | |||||
| NeoPharm Co. , Ltd. | Gel | Topical | 2.5 g/100 g | 2010 | |
| 
 Indications
 | |||||
| LIFElabs, a Division of Atico International USA, INC. | Gel | Topical | 25 mg/1 g | 2010 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Gel | Topical | 37 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| Anicare Pharmaceuticals Pvt. Ltd | Gel | Topical | 0.025 g/1 g | 2015 | |
| 
 Indications
 | |||||
| MEDZONE PRODUCTS LLC | Cream | Topical | 35 mg/1 g | 2019 | |
| 
 | |||||
| OL PHARMA TECH, LLC | Gel | Topical | 25 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| Personal Care Products, Inc. | Cream | Topical | 1.05 g/42 g | 2013 | |
| 
 Indications
 | |||||
| Universal Distribution Center LLC | Gel | Topical | 0.025 g/1 g | 2015 | |
| 
 Indications
 | |||||
| Universal Distribution Centre LLC | Gel | Topical | 25 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| Universal Distribution Centre LLC | Gel | Topical | 25 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| Aidance Scientific, Inc. , DBA Aidance Skincare & Topical Solutions | Cream | Topical | 4 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Inspec Solutions LLC. | Gel | Topical | 6 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| Inspec Solutions LLC | Spray | Topical | 15.75 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| Inspec Solutions LLC. | Gel | Topical | 6 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| Inspec Solutions | Gel | Topical | 6 g/100 g | 2024 | |
| 
 | |||||
| Sunascen Therapeutics LLC | Gel | Topical | 35 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Patchv3 Vitamins Ltd | Tape | Topical | 10 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Herba Enterprise Inc | Lotion | Topical | 60 mg/1 mL | 2014 | |
| 
 Indications
 | |||||
| Natoral Limited | Mouthwash | Oral | 0.3 mg/1 mL | 2017 | |
| 
 Indications
 | |||||
| NATURAL 17 | Spray | Topical | 1.7 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 4.8 mg | 2023 | |
| 
 Indications
 | |||||
| BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 4.8 mg | 2020 | |
| 
 Indications
 | |||||
| BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 4.8 mg | 2021 | |
| 
 Indications
 | |||||
| Target Corporation Inc. | Pastille | Oral | 4.8 mg | 2020 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 2.0 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 2.0 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 3.5 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 3.5 mg | 1942 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Lotion | Topical | 2.8 g/224 g | 2024 | |
| 
 Indications
 | |||||
| EROS GLOBAL CORP | Oil | Topical | 8 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Natureplex LLC | Cream | Topical | 2.5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Unipack, Inc. | Gel | Topical | 2 g/100 g | 2014 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Spray | Topical | 160 mg/1 g | 2024 | |
| 
 Indications
 | |||||
| Natures Sunshine Products, Inc. | Cream | Topical | 1.25 g/100 g | 2010 | |
| 
 | |||||
| Wasatch Product Development, LLC | Cream | Topical | 1.25 g/100 g | 2010 | |
| 
 | |||||
| WB VENTURES LLC | Cream | Topical | 30 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| WB Ventures LLC | Cream | Topical | 10 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| WB Ventures LLC | Liquid | Topical | 30 mg/1 mL | 2025 | |
| 
 Indications
 | |||||
| WB Ventures LLC | Cream | Topical | 10 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| NeilMed Pharmaceuticals Inc. | Spray | Topical | 0.16 g/1 g | 2020 | |
| 
 Indications
 | |||||
| Guoyu Trading Co. , Ltd. | Patch | Topical | 0.5 g/100 1 | 2024 | |
| 
 | |||||
| Guoyu Trading Co. , Ltd. | Patch | Topical | 1 g/100 1 | 2024 | |
| 
 Indications
 | |||||
| TOP DOG DIRECT, LLC | Cream | Topical | 30 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Pogue Medical Services | Cream | Topical | 40 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| ANC Amazon Natural Corp. | Spray | Topical | 5 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
| 
 Indications
 | |||||
| Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
| 
 Indications
 | |||||
| Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
| 
 Indications
 | |||||
| Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
| 
 Indications
 | |||||
| Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
| 
 Indications
 | |||||
| PLUM VALLEYPHARMA LLC | Cream | Topical | 3.7 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Compes Cosmetic | Cream | Topical | 10 mg/100 mg | 2017 | |
| 
 Indications
 | |||||
| Lugus Group LLC | Cream | Topical | 10 mg/100 mg | 2014 | |
| 
 Indications
 | |||||
| LUGUS GROUP LLC | Spray | Topical | 0.1 mg/100 mg | 2016 | |
| 
 Indications
 | |||||
| Lugus Group LLC | Aerosol, Spray | Topical | 5 mg/100 mg | 2017 | |
| 
 Indications
 | |||||
| Lugus Group LLC | Liquid | Topical | 10 mg/100 mg | 2017 | |
| 
 Indications
 | |||||
| Lugus Group LLC | Aerosol, Spray | Topical | 5 mg/100 mg | 2018 | |
| 
 Indications
 | |||||
| Lugus Group LLC | Aerosol, Foam | Topical | 5 mg/100 mg | 2014 | |
| 
 Indications
 | |||||
| Vema Industrie-Verpackung | Aerosol, Foam | Topical | 5 mg/100 mg | 2017 | |
| 
 Indications
 | |||||
| Vema Industrie-Verpackung | Cream | Topical | 10 mg/100 mg | 2017 | |
| 
 Indications
 | |||||
| Vema Industrie-verpackung Gmbh & Co. Kg. Kontrakt - Abfullung Und -verpackung | Aerosol, Spray | Topical | 5 mg/100 mg | 2017 | |
| 
 Indications
 | |||||
| Vema Industrie-verpackung Gmbh & Co. Kg. Kontrakt - Abfullung Und -verpackung | Spray | Topical | 0.1 mg/100 mg | 2016 | |
| 
 Indications
 | |||||
| DreamAir Co. , | Liquid | Topical | 0.2 g/10 mL | 2016 | |
| 
 Indications
 | |||||
| Xcentrik Inc. | Cream | Topical | 3 g/100 g | 2019 | |
| 
 Indications
 | |||||
| NOVUM SOLUTIONS INC | Spray | Topical | 0.5 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
| 
 Indications
 | |||||
| Hobart Laboratories, Inc. | Ointment | Topical | 1.25 g/100 g | 2011 | |
| 
 Indications
 | |||||
| NUTRASTATE, LLC | Gel | Topical | 4 g/100 g | 2020 | |
| 
 Indications
 | |||||
| NUTRASTATE, LLC | Gel | Topical | 4 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Nuturna International LLC | Cream | Topical | 3.7 g/100 g | 2020 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
| 
 Indications
 | |||||
| Phytopia Co. , Ltd. | Oil | Transdermal | 100 mg/50 mL | 2016 | |
| 
 Indications
 | |||||
| NATURAL ESSENTIALS, INC. | Gel | Topical | 100 mg/1 g | 2024 | |
| 
 Indications
 | |||||
| Jakemans (Confectioners) Limited | Lozenge | Oral | 10 mg | 2010 | |
| 
 Indications
 | |||||
| Guangzhou ChuanMa International Trading Co. , Ltd. | Cream | Topical | 1 g/100 g | 2025 | |
| 
 | |||||
| WORLD WIDE MEDICAL SERVICES, INC. | Gel | Topical | 3.9 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Liquid | Topical | 4.2 g/84 g | 2021 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, INC. | Liquid | Topical | 4.2 g/84 g | 2021 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2021 | |
| 
 Indications
 | |||||
| Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2021 | |
| 
 Indications
 | |||||
| Lofthouse of Fleetwood, Ltd. | Lozenge | Oral | 10 mg | 2010 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 5.5 mg | 2022 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 5.5 mg | 2022 | |
| 
 Indications
 | |||||
| Valda USA Labeler | Lozenge | Oral | 3.6 mg | 2024 | |
| 
 Indications
 | |||||
| LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 g | 2025 | |
| 
 Indications
 | |||||
| LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| Sarati International, Inc. | Cream | Topical | 1.3 g/100 g | 2016 | |
| 
 Indications
 | |||||
| PHYTOPIA CO. , LTD. | Oil | Topical | 7 mg/50 mL | 2016 | |
| 
 | |||||
| Walgreen Co. | Gel | Topical | 36 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.04 g/1 g | 2025 | |
| 
 Indications
 | |||||
| Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2022 | |
| 
 Indications
 | |||||
| OWELL NATURALS BRAND, LLC | Ointment | Topical | 76.6 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Owell Naturals Brand LLC | Cream | Topical | 8 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Back to Earth Inc. | Cream | Topical | 9.6 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Genexa Inc. | Gel | Topical | 7 g/100 mL | 2018 | |
| 
 Indications
 | |||||
| Austin Biotechnology Inc | Cream | Topical | 14 g/280 g | 2011 | |
| 
 Indications
 | |||||
| Natures Formulae Health Products Ltd. | Granule | Topical | 1.6 mg/1 g | 2016 | |
| 
 | |||||
| Natures Formulae Health Products Ltd. | Oil | Topical | 17.62 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| Natures Formulae Health Products Ltd. | Oil | Topical | 12.18 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Granule | Topical | 1.6 mg/1 g | 2016 | |
| 
 | |||||
| Saje Natural Business Inc. | Oil | Topical | 17.62 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Oil | Topical | 12.18 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Liquid | Topical | 2.23 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Cream | Topical | 2.667 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Australis Capital (Nevada) Inc. | Gel | Topical | 4 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| Better Living Brands | Spray | Topical | 10.5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| J. R. Watkins, LLC. | Aerosol, Spray | Topical | 6 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| J. R. Watkins, LLC. | Gel | Topical | 6 g/100 g | 2020 | |
| 
 Indications
 | |||||
| J. R. Watkins, LLC. | Patch | Topical | 105 mg | 2022 | |
| 
 Indications
 | |||||
| Pain Relieving Spray Inc. | Aerosol, Spray | Topical | 70 mg/1 L | 2025 | |
| 
 Indications
 | |||||
| Sagely Enterprises Inc. | Spray | Topical | 10 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2025 | |
| 
 Indications
 | |||||
| Unifirst First Aid Corporation | Spray | Topical | 70 mg/1 L | 2019 | |
| 
 Indications
 | |||||
| HEMPFUSION, INC. | Cream | Topical | 40 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| SOTAC PHARMACEUTICAL PRIVATE LIMITED | Gel | Topical | 40 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Cosmetic Specialty labs, Inc. | Cream | Topical | 6 g/100 mL | 2018 | |
| 
 Indications
 | |||||
| HEMPFUSION, INC. | Cream | Topical | 17.5 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Sagely Enterprises Inc. | Cream | Topical | 5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| SanaMax Plus LLC | Cream | Topical | 1.25 g/100 g | 2019 | |
| 
 Indications
 | |||||
| HEMPFUSION, INC. | Gel | Topical | 15 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| R & Y Group, LLC | Gel | Topical | 0.04 g/1 mL | 2023 | |
| 
 Indications
 | |||||
| Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2022 | |
| 
 Indications
 | |||||
| Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2022 | |
| 
 Indications
 | |||||
| Great Lakes Wholesale, Marking, and Sales, Inc. | Liquid | Topical | 0.16 g/1 mL | 2016 | |
| 
 Indications
 | |||||
| J. R. Watkins, LLC. | Gel | Topical | 6 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Sagely Enterprises Inc. | Liquid | Topical | 10 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Better Living | Gel | Topical | 4 g/100 mL | 2018 | |
| 
 Indications
 | |||||
| Great Lakes Wholesale, Marketing, and Sales, Inc | Patch | Topical | 160 mg/1 mL | 2016 | |
| 
 Indications
 | |||||
| Sagely Enterprises Inc. | Stick | Topical | 10 g/100 g | 2021 | |
| 
 Indications
 | |||||
| UNITED EXCHANGE CORP | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| CA-BOTANA INTERNATIONAL | Gel | Topical | 2.4 g/120 g | 2011 | |
| 
 | |||||
| Safetec of America, Inc. | Gel | Topical | 4 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Safetec of America, Inc. | Spray | Topical | 7 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 L | 2016 | |
| 
 Indications
 | |||||
| AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 L | 2016 | |
| 
 Indications
 | |||||
| J. R. Watkins, LLC. | Gel | Topical | 3 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Rite Aid | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Heilongjiang Huashen Science & Technology Development Co Ltd | Patch | Topical | 0.2 | 2010 | |
| 
 Indications
 | |||||
| Walgreen Co. | Patch | Topical | .05 mg/1 g | 2013 | |
| 
 Indications
 | |||||
| CVS PHARMACY, INC. | Patch | Topical | 50 mg/1 g | 2013 | |
| 
 Indications
 | |||||
| Safetec of America, Inc. | Gel | Topical | 7 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| Koi CBD LLC | Gel | Topical | 100 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| OL PHARMA TECH, LLC | Gel | Topical | 25 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| VIZURI HEALTH SCIENCES LLC | Patch | Topical | 6 g | 2021 | |
| 
 Indications
 | |||||
| VIZURI HEALTH SCIENCES LLC | Patch | Topical | 6 g | 2022 | |
| 
 Indications
 | |||||
| PainFix LLC | Gel | Topical | 50 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| PainFix LLC | Patch | Topical | 70 mg/1 g | 2022 | |
| 
 Indications
 | |||||
| PainFix LLC | Patch | Topical | 30 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| SmartScience Laboratories, Inc. | Gel | Topical | 85 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| SmartScience Laboratories, Inc. | Gel | Topical | 85 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| MEDZONE PRODUCTS LLC | Cream | Topical | 35 mg/1 g | 2019 | |
| 
 | |||||
| Enzyme Labs | Cream | Topical | 4.25 g/85 g | 2010 | |
| 
 Indications
 | |||||
| NHR SCIENCE CORP | Cream | Topical | 15 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Meds Direct Rx of NY LLC | Patch | Topical | 5 g/100 g | 2014 | |
| 
 | |||||
| Safeway | Lozenge | Oral | 5.4 mg | 2018 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 35 mg/1 mL | 2015 | |
| 
 Indications
 | |||||
| RB Health (US) LLC | Gel | Topical | 35 mg/1 mL | 2015 | |
| 
 Indications
 | |||||
| Delta Brands & Products LLC | Gel | Topical | 1.25 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Personal Care Products, Inc. | Powder | Topical | 20 mg/2 g | 2009 | |
| 
 Indications
 | |||||
| PERSONAL CARE PRODUCTS, LLC | Patch | Topical | 50 mg | 2011 | |
| 
 | |||||
| NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO. , LTD. | Gel | Topical | 1.25 g/100 g | 2017 | |
| 
 Indications
 | |||||
| Personal Care Products, Inc. | Gel | Topical | 1 g/100 g | 2010 | |
| 
 Indications
 | |||||
| American Consumer Products Corp | Gel | Topical | 1 g/100 g | 2018 | |
| 
 Indications
 | |||||
| ER3 BRANDS INC. | Cream | Topical | 10 mg/1 mL | 2025 | |
| 
 Indications
 | |||||
| Pure Source, LLC | Cream | Topical | 20 mg/1 mL | 2013 | |
| 
 Indications
 | |||||
| Acme United Corporation | Lozenge | Oral | 7.6 mg | 2015 | |
| 
 Indications
 | |||||
| Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| PlayMakar Inc. | Gel | Topical | 60 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| PO SUM ON MEDICINE FACTORY LIMITED | Ointment | Topical | 13 g/100 g | 2017 | |
| 
 Indications
 | |||||
| PO SUM ON MEDICINE FACTORY LIMITED | Oil | Topical | 15 g/100 mL | 2004 | |
| 
 Indications
 | |||||
| Fabrication Enterprises | Gel | Topical | 120 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| FABRICATION ENTERPRISES | Gel | Topical | 120 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Fabrication Enterprises | Gel | Topical | 120 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Fabrication Enterprises | Liquid | Topical | 140 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| Mettler Electronics Corp. | Gel | Topical | 40 mg/1 mL | 2002 | |
| 
 Indications
 | |||||
| Clientele, Inc. | Gel | Topical | 2 mL/100 mL | 2004 | |
| 
 Indications
 | |||||
| Amphp, Inc | Lotion | Topical | 0.5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Pharmacy Value Alliance LLC | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Pharmacy Value Alliance LLC | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Pharmacy Value Alliance LLC | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Pharmacy Value Alliance LLC | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Premiere Enterprises | Spray | Topical | 0.07 g/1 mL | 2010 | |
| 
 Indications
 | |||||
| Premiere Enterprises | Spray | Topical | 7 g/100 mL | 2011 | |
| 
 Indications
 | |||||
| Premiere Enterprises | Spray | Topical | 7 g/100 mL | 2011 | |
| 
 Indications
 | |||||
| DOBEST INC | Cream | Topical | 80 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| TWIN MED, LLC | Gel | Topical | 5 g/100 g | 2016 | |
| 
 Indications
 | |||||
| New Leaf Pharmaceutical, LLC | Spray | Topical | 10.5 g/10.5 mL | 2019 | |
| 
 | |||||
| NATURE'S FUSIONS, LLC | Cream | Topical | 4 g/60 mL | 2022 | |
| 
 | |||||
| Guangzhou Haishi Biological Technology Co. , Ltd. | Cream | Topical | 10 g/100 g | 2025 | |
| 
 | |||||
| AHC VENTURES | Spray | Topical | 8 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| ACH VENTURES CORP | Gel | Topical | 8 g/100 mL | 2016 | |
| 
 Indications
 | |||||
| New Leaf Pharmaceutical, LLC | Gel | Topical | 10.5 g/10.5 mL | 2020 | |
| 
 | |||||
| New Leaf Pharmaceutical, LLC | Ointment | Topical | 16 g/16 mg | 2020 | |
| 
 | |||||
| PURE PERSONAL CARE, LLC | Cream | Topical | 75 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| CHAIN DRUG MARKETING ASSOCIATION INC | Patch | Topical | 400 mg | 2011 | |
| 
 Indications
 | |||||
| Quality Home Products | Patch | Topical | 400 mg | 2011 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association Inc | Liquid | Topical | 16 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg | 2023 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association, Inc. | Lozenge | Oral | 5.8 mg | 2024 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association, Inc. | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2024 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2024 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association, Inc. | Lozenge | Oral | 7.5 mg | 2024 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association, Inc. | Lozenge | Oral | 7.6 mg | 2024 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association, Inc. | Lozenge | Oral | 5.4 mg | 2024 | |
| 
 Indications
 | |||||
| Chain Drug Marketing Association | Gel | Topical | 2.5 g/100 g | 2011 | |
| 
 Indications
 | |||||
| Quality Home Products | Gel | Topical | 2.5 g/100 g | 2011 | |
| 
 Indications
 | |||||
| Access Business Group International LLC | Cream | Topical | 1.25 g/100 g | 2010 | |
| 
 Indications
 | |||||
| EEZAWAY RELIEF INC | Liquid | Topical | 2.75 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2024 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Liquid | Topical | 100 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| RAPID AID VIET NAM CO. , LTD | Patch | Topical | 4.26 g/100 g | 2024 | |
| 
 Indications
 | |||||
| RAPID AID VIET NAM CO. , LTD | Patch | Topical | 5 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Rapid-Ease | Cream | Topical | 12.5 mg/1 g | 2019 | |
| 
 Indications
 | |||||
| Raw Health International, LLC | Liquid | Topical | 34.86 g/1 L | 2013 | |
| 
 Indications
 | |||||
| Rescue Dog Health | Gel | Topical | 3.5 mg/1 L | 2014 | |
| 
 Indications
 | |||||
| Raw Health International, LLC | Liquid | Topical | 34.79 g/1 L | 2013 | |
| 
 Indications
 | |||||
| Rescue Dog Health | Gel | Topical | 3.5 mg/1 L | 2014 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2016 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.03 g/1 g | 2022 | |
| 
 Indications
 | |||||
| Rejuventus, Inc. | Cream | Topical | 118.29 mL/100 mL | 2011 | |
| 
 | |||||
| Cosmetic Specialty Labs, Inc. | Lotion | Topical | 1.25 g/100 mL | 2013 | |
| 
 Indications
 | |||||
| Real Time Products Inc. | Cream | Topical | 15 mg/1 g | 2024 | |
| 
 Indications
 | |||||
| Cosmetic Specialty labs, Inc. | Cream | Topical | 1.5 g/100 g | 2013 | |
| 
 Indications
 | |||||
| Cosmetic Specialty Labs, Inc. | Lotion | Topical | 1.5 g/100 mL | 2014 | |
| 
 Indications
 | |||||
| Real Time Products Inc. | Lotion | Topical | 19 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| REAL TIME PRODUCTS, INC | Lotion | Topical | 15 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Cosmetic Specialty labs, Inc. | Lotion | Topical | 0.5 g/100 mL | 2013 | |
| 
 Indications
 | |||||
| Cosmetic Specialty Labs, Inc. | Lotion | Topical | 1.25 g/100 mL | 2013 | |
| 
 Indications
 | |||||
| VRB Labs, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| The Anthos Group | Spray | Topical | 10.5 g/100 mL | 2020 | |
| 
 | |||||
| Saje Natural Business Inc. | Ointment | Topical | 12.7 mg/1 g | 2016 | |
| 
 Indications
 | |||||
| Cosmetic Specialty labs, Inc. | Cream | Topical | 3 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Redicare LLC | Lozenge | Oral | 7.6 mg/100 mg | 2025 | |
| 
 Indications
 | |||||
| Inspec Solutions LLC. | Spray | Topical | 10.5 g/100 g | 2024 | |
| 
 Indications
 | |||||
| La Mend, Inc. | Patch | Topical | 5 g/100 g | 2024 | |
| 
 Indications
 | |||||
| Corganics, LP | Cream | Topical | 2.5 g/100 g | 2004 | |
| 
 Indications
 | |||||
| Corganics, LP | Cream | Topical | 3.0 g/100 g | 2004 | |
| 
 Indications
 | |||||
| Proximity Capital Partners LLC dba Asutra | Cream | Topical | 10 g/100 g | 2021 | |
| 
 Indications
 | |||||
| SOLITEINT Kozmetikum gyarto es forgalmazo, termelo es kereskedelmi Korlatolt Felelossegu Tarsasag | Cream | Topical | 10 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Cosmetic Specialty labs, Inc. | Liquid | Topical | 1.2 mg/15 mL | 2020 | |
| 
 Indications
 | |||||
| Natures Formulae Health Products Ltd. | Ointment | Topical | 0.2 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Ointment | Topical | 0.2 g/100 g | 2018 | |
| 
 Indications
 | |||||
| International Nutraceutical Company of America (INCA) , LLC | Ointment | Topical | 937.5 mg/1 g | 2012 | |
| 
 Indications
 | |||||
| EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2021 | |
| 
 Indications
 | |||||
| EEZAWAY RELIEF INC | Liquid | Topical | 2.75 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| Dolgencorp, LLC | Gel | Topical | 2 g/100 g | 2018 | |
| 
 Indications
 | |||||
| DOLGENCORP, LLC | Gel | Topical | 27.5 mg/1 g | 2011 | |
| 
 Indications
 | |||||
| PHYTOPIA CO. , LTD. | Oil | Topical | 7 mg/50 mL | 2016 | |
| 
 | |||||
| Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Cream | Topical | 2 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 8.3 mg | 2022 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2022 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 8.3 mg | 2022 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2022 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 8.3 mg | 2022 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2022 | |
| 
 Indications
 | |||||
| Rite Aid Corporation | Patch | Topical | 50 g | 2010 | |
| 
 Indications
 | |||||
| Rite Aid | Gel | Topical | 40 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Rite Aid | Spray | Topical | 10.5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Rite Aid | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Rite Aid | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Rite Aid Corporation | Patch | Topical | 5 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Rite Aid | Liquid | Topical | 16 g/100 g | 2023 | |
| 
 Indications
 | |||||
| SOTAC PHARMACEUTICALS PRIVATE LIMITED | Gel | Topical | 40 mg | 2018 | |
| 
 Indications
 | |||||
| Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Ningbo Pulisi Daily Chemical Products Co. , Ltd. | Cream | Topical | 6 mg/100 mL | 2017 | |
| 
 Indications
 | |||||
| Ningbo Pulisi Daily Chemical Products Co. , Ltd. | Cream | Topical | 0.006 g/0.1 g | 2017 | |
| 
 Indications
 | |||||
| NINGBO SANTE YING MEDICALAND HEALTHDEVELOPMENT CO. , LTD | Cream | Topical | 6 mg/100 mL | 2019 | |
| 
 Indications
 | |||||
| NINGBO SANTE YING MEDICALAND HEALTHDEVELOPMENT CO. , LTD | Gel | Topical | 6.0 g/100 g | 2019 | |
| 
 Indications
 | |||||
| NINGBO SANTE YING MEDICALAND HEALTHDEVELOPMENT CO. , LTD | Gel | Topical | 6.0 g/100 g | 2019 | |
| 
 Indications
 | |||||
| Implus Footcare, LLC | Gel | Topical | 8.3 g/88.5 mL | 2021 | |
| 
 Indications
 | |||||
| Implus Footcare, LLC | Gel | Topical | 33.2 g/355 mL | 2021 | |
| 
 Indications
 | |||||
| New Leaf Pharmaceutical, LLC | Spray | Topical | 4 g/4 mL | 2019 | |
| 
 | |||||
| Awesome Trading, LLC | Cream | Topical | 50 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Rugby Laboratories, Inc. | Gel | Topical | 20 mg/1 g | 2015 | |
| 
 Indications
 | |||||
| RUGBY LABORATORIES | Patch | Topical | 5 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Saint Medicine, Inc. | Liquid | Respiratory (inhalation) | 3.2 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| Alquimia Najulam S de RL de CV | Gel | Topical | 150 mg/1 g | 2018 | |
| 
 Indications
 | |||||
| SanaMax Plus LLC | Cream | Topical | 4.0 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| Miracle Balance, LLC | Cream | Topical | 50 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Q. A. Laboratories | Cream | Topical | 4 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Sella Natural Cosmetics Co. , Ltd. | Paste, Dentifrice | Topical | 0.2 g/100 g | 2014 | |
| 
 | |||||
| Target Corporation Inc. | Pastille | Oral | 20 mg | 2024 | |
| 
 Indications
 | |||||
| Target Corporation Inc. | Pastille | Oral | 0.69 mg | 2019 | |
| 
 Indications
 | |||||
| Cardinal Health | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| Rite Aid | Lozenge | Oral | 7.6 mg | 2011 | |
| 
 Indications
 | |||||
| Walgreen Co. | Lozenge | Oral | 7.6 mg | 2016 | |
| 
 Indications
 | |||||
| Dolgencorp, LLC | Lozenge | Oral | 7.6 mg | 2018 | |
| 
 Indications
 | |||||
| Meijer Distribution | Lozenge | Oral | 7.6 mg | 2018 | |
| 
 Indications
 | |||||
| The Kroger Co. | Lozenge | Oral | 7.6 mg | 2014 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 5.8 mg | 2012 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. dba UNFI | Lozenge | Oral | 5.8 mg | 2014 | |
| 
 Indications
 | |||||
| Walgreen Co. | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Corporativo Serysi S de R L de C V | Gel | Topical | 12.5 mg/1 g | 2017 | |
| 
 | |||||
| Corporativo Serysi S de R L de C V | Gel | Topical | 12.6 mg/1 g | 2017 | |
| 
 | |||||
| Corporativo Serysi S de R L de C V | Gel | Topical | 2.6 mg/100 g | 2017 | |
| 
 | |||||
| Shield and Heal Inc. | Stick | Topical | 10 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| Safeway | Lozenge | Oral | 5.8 mg | 2020 | |
| 
 Indications
 | |||||
| Safeway | Patch | Topical | 50 mg | 2015 | |
| 
 Indications
 | |||||
| Safeway | Lozenge | Oral | 7.5 mg | 2020 | |
| 
 Indications
 | |||||
| Safeway | Patch | Topical | 5 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Safeway | Gel | Topical | 4 g/1 mL | 2024 | |
| 
 Indications
 | |||||
| ALPHA PLANTS INC | Cream | Topical | 80 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Sinsin Pharmaceutical Co. , Ltd. | Patch | Topical | 0.85 g/17 g | 2018 | |
| 
 Indications
 | |||||
| Avon Products, Inc. | Spray | Topical | 5 mg/1 mL | 2012 | |
| 
 Indications
 | |||||
| Kmart Corporation | Patch | Topical | 750 mg | 2013 | |
| 
 | |||||
| Smooth Gator LLC | Cream | Topical | 30 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Natumin Pharma AB | Gel | Topical | 2.25 g/100 g | 2015 | |
| 
 | |||||
| RENU LABORATORIES, INC. | Liquid | Topical | 0.84 g/28 g | 2022 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2016 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
| 
 Indications
 | |||||
| Sombra Cosmetics Inc. | Gel | Topical | 0.06 g/1 g | 2022 | |
| 
 Indications
 | |||||
| Sombra Cosmetics Inc. | Gel | Topical | 0.06 g/1 g | 2022 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2020 | |
| 
 Indications
 | |||||
| Clay Therapy | Cream | Topical | 25 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Clientele, Inc. | Gel | Topical | 2 mg/100 mL | 2014 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2016 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2022 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2022 | |
| 
 Indications
 | |||||
| United Exchange Corp. | Patch | Topical | 50 mg/1 g | 2015 | |
| 
 | |||||
| Kareway Product, Inc. | Patch | Topical | 400 mg | 2018 | |
| 
 Indications
 | |||||
| Inspec Solutions LLC. | Cream | Topical | 8 g/100 g | 2023 | |
| 
 Indications
 | |||||
| HEMPFUSION, INC. | Cream | Topical | 40 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| HEMPFUSION, INC. | Cream | Topical | 17.5 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| MIKYEONG KOREA CO. , LTD | Liquid | Topical | 4 g/100 mL | 2021 | |
| 
 | |||||
| Natural Essentials Inc. | Liquid | Topical | 100 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2022 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2017 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2017 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Liquid | Topical | 100 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2017 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 g | 2023 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Spray | Topical | 80 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 g | 2025 | |
| 
 Indications
 | |||||
| Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Walgreen Co. | Lozenge | Oral | 2.7 mg | 2016 | |
| 
 Indications
 | |||||
| BestCo Inc. | Lozenge | Oral | 2.7 mg | 2011 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 2.7 mg | 2016 | |
| 
 Indications
 | |||||
| HEB | Lozenge | Oral | 2.7 mg | 2018 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 2.7 mg | 2013 | |
| 
 Indications
 | |||||
| Stressa Incorporated | Oil | Topical | 1 g/93 mL | 2014 | |
| 
 Indications
 | |||||
| Stressa Incorporated | Cream | Topical | 1.25 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| Publix | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| Winco Foods | Lozenge | Oral | 5.8 mg | 2014 | |
| 
 Indications
 | |||||
| Lofthouse of Fleetwood, Ltd. | Lozenge | Oral | 6.9 mg | 2010 | |
| 
 Indications
 | |||||
| Cardinal Health 110, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 5.8 mg | 2025 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 7.6 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
| 
 Indications
 | |||||
| Cardinal Health 110, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
| 
 Indications
 | |||||
| Cardinal Health 110, Inc. | Pastille | Oral | 7.6 mg | 2023 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 4.1 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 4.1 mg | 1942 | |
| 
 Indications
 | |||||
| American Sales | Lozenge | Oral | 7.6 mg | 2016 | |
| 
 Indications
 | |||||
| Bestco Inc. | Lozenge | Oral | 7.6 mg | 2018 | |
| 
 Indications
 | |||||
| Big Lots | Lozenge | Oral | 7.6 mg | 2017 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 7.6 mg | 2015 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 7.6 mg | 2016 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 7.6 mg | 2016 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 7.6 mg | 2017 | |
| 
 Indications
 | |||||
| Publix | Lozenge | Oral | 7.6 mg | 2018 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 7.6 mg | 2013 | |
| 
 Indications
 | |||||
| United Natural Foods, Inc. dba UNFI | Lozenge | Oral | 7.6 mg | 2018 | |
| 
 Indications
 | |||||
| Walgreen | Lozenge | Oral | 7.6 mg | 2019 | |
| 
 Indications
 | |||||
| Walmart | Lozenge | Oral | 7.6 mg | 2018 | |
| 
 Indications
 | |||||
| Lofthouse of Fleetwood, Ltd. | Lozenge | Oral | 5.52 mg | 2019 | |
| 
 | |||||
| United Natural Foods, Inc. dba UNFI | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| American Sales | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| CVS Pharmacy | Lozenge | Oral | 5.8 mg | 2015 | |
| 
 Indications
 | |||||
| Dollar General Corporation | Lozenge | Oral | 5.8 mg | 2016 | |
| 
 Indications
 | |||||
| Meijer | Lozenge | Oral | 5.8 mg | 2017 | |
| 
 Indications
 | |||||
| Publix | Lozenge | Oral | 5.8 mg | 2018 | |
| 
 Indications
 | |||||
| Topco Associates | Lozenge | Oral | 5.8 mg | 2013 | |
| 
 Indications
 | |||||
| Walmart Stores Inc | Lozenge | Oral | 5.8 mg | 2014 | |
| 
 Indications
 | |||||
| Winco Foods | Lozenge | Oral | 5.8 mg | 2014 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 4.8 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 4.8 mg | 1942 | |
| 
 Indications
 | |||||
| RENU LABORATORIES, LLC | Cream | Topical | 5.9 g/118 mL | 2023 | |
| 
 Indications
 | |||||
| Sunflora Inc. | Spray | Topical | 6 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| SUNSET NOVELTIES, INC | Stick | Topical | 10 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| BLUE SPRING WELLNESS | Cream | Topical | 14 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2021 | |
| 
 Indications
 | |||||
| Superior Trading Company | Liniment | Transdermal | 3.5 mg/100 mL | 2009 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Oil | Topical | 24.56 mg/1 mL | 2016 | |
| 
 | |||||
| iON Pharma, LLC | Gel | Topical | 4 g | 2025 | |
| 
 Indications
 | |||||
| Davion, Inc | Powder | Topical | 0.15 g/100 g | 2018 | |
| 
 Indications
 | |||||
| TARGET CORPORATION | Gel | Topical | 40 mg/1 mL | 2023 | |
| 
 Indications
 | |||||
| Sod-e Biotech Ltd | Cream | Topical | 12.5 mg/1 g | 2024 | |
| 
 Indications
 | |||||
| PHYTOPIA CO. , LTD. | Oil | Topical | 1.3 mg/50 mg | 2016 | |
| 
 | |||||
| Carbon Innovation, Inc. | Patch | Topical | 4 g/100 g | 2017 | |
| 
 Indications
 | |||||
| Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Cream | Topical | 2 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Cream | Topical | 2 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 5.3 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola Ag | Lozenge | Oral | 4.8 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 4.8 mg | 1942 | |
| 
 Indications
 | |||||
| Ricola USA Inc. | Lozenge | Oral | 5.3 mg | 1942 | |
| 
 Indications
 | |||||
| Symedic LLC | Gel | Topical | 4 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| The Cream Skateboarding Liniment Pty Ltd | Cream | Topical | 130 mg/1 g | 2018 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Fourstar Group USA, Inc. | Gel | Topical | 40 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| Fourstar Group USA, Inc. | Liquid | Topical | 160 mg/1 mL | 2024 | |
| 
 Indications
 | |||||
| FOURSTAR GROUP USA, INC. | Gel | Topical | 25 mg/1 g | 2025 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Patch | Topical | 5 g | 2024 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Gel | Topical | 20 mg/1 g | 2022 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Gel | Topical | 25 mg/1 g | 2021 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Liquid | Topical | 0.16 g/1 mL | 2025 | |
| 
 Indications
 | |||||
| Veridian Healthcare | Gel | Topical | 4 g/1 mL | 2025 | |
| 
 Indications
 | |||||
| SOMBRA COSMETICS INC. | Gel | Topical | .04 g/1 g | 2013 | |
| 
 Indications
 | |||||
| SKIN SHERPA NORTH AMERICA LLC | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| SKIN SHERPA NORTH AMERICA LLC | Gel | Topical | 40 mg/1 mL | 2022 | |
| 
 Indications
 | |||||
| Epic Laboratories, LLC | Liquid | Topical | 2 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| TopCare | Gel | Topical | 2 g/100 g | 2012 | |
| 
 Indications
 | |||||
| APEX-CAREX HEATHCARE PRODUCTS | Gel | Topical | 3.9 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| APEX-CAREX HEATHCARE PRODUCTS | Gel | Topical | 3.9 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| APEX-CAREX HEATHCARE PRODUCTS | Spray | Topical | 6 g/100 mL | 2015 | |
| 
 Indications
 | |||||
| Product Quest Mfg | Gel | Topical | 2 g/100 g | 2017 | |
| 
 Indications
 | |||||
| Thompson Safety LLC | Lozenge | Oral | 7.6 mg | 2021 | |
| 
 Indications
 | |||||
| Binger Consulting Corporation | Patch | Topical | 5 g/100 g | 2015 | |
| 
 Indications
 | |||||
| Phytoneering Extract Solutions GmbH | Pastille | Oral | 2.5 mg | 2005 | |
| 
 Indications
 | |||||
| Traditional Medicinals, Inc. | Lozenge | Oral | 6 mg/4.2 g | 2020 | |
| 
 Indications
 | |||||
| Traditional Medicinals, Inc. | Lozenge | Oral | 6 mg/4.2 g | 2020 | |
| 
 Indications
 | |||||
| Shenzhen Sam Technology Co. , Ltd. | Cream | Topical | 5 g/0.1 L | 2025 | |
| 
 Indications
 | |||||
| The Anthos Group, Inc | Liquid | Topical | 10.5 g/100 mL | 2023 | |
| 
 Indications
 | |||||
| Shenzhen Sam Technology Co. , Ltd. | Spray | Topical | 10.5 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Shenzhen Sam Technology Co. , Ltd. | Spray | Topical | 10.5 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Shenzhen Sam Technology Co. , Ltd. | Spray | Topical | 10.5 g/100 mL | 2024 | |
| 
 Indications
 | |||||
| Shenzhen Sam Technology Co. , Ltd. | Cream | Topical | 4 g/100 mL | 2025 | |
| 
 Indications
 | |||||
| ANTHOS GROUP, INC, THE | Cream | Topical | 2 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| ANTHOS GROUP, INC, THE | Spray | Topical | 10.5 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| Guangzhou Hanhai Trading Co. , Ltd | Patch | Topical | 19 g/100 1 | 2023 | |
| 
 Indications
 | |||||
| LAB-O Corp | Ointment | Topical | 24 mg/1 g | 2020 | |
| 
 Indications
 | |||||
| IDEAZ, LLC | Cream | Topical | 4 g/100 g | 2025 | |
| 
 Indications
 | |||||
| Tommie Copper, Inc. | Spray | Topical | 16 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Patch | Topical | 50 mg | 2019 | |
| 
 | |||||
| Topco Associates LLC | Liquid | Topical | 160 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Topco Associates LLC | Gel | Topical | 40 mg/1 mL | 2020 | |
| 
 Indications
 | |||||
| Dermaline USA Corp | Gel | Topical | 1 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Youngevity International Inc. | Cream | Topical | 1.4 g/100 g | 2020 | |
| 
 Indications
 | |||||
| AmperSand Biopharma | Lotion | Topical | 0.5 g/100 g | 2017 | |
| 
 | |||||
| Icure Pharmaceutical Inc, Wanju Factory | Patch | Topical | 150 mg | 2020 | |
| 
 Indications
 | |||||
| Icure Pharmaceutical Inc, Wanju Factory | Patch | Topical | 300 mg | 2020 | |
| 
 Indications
 | |||||
| Icure Pharmaceutical Inc, Wanju Factory | Patch | Topical | 375 mg | 2020 | |
| 
 Indications
 | |||||
| Electrostim Medical Services Inc. d/b/a EMSI | Gel | Topical | 5.0 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| Electrostim Medical Services Inc. d/b/a EMSI | Spray | Topical | 10.5 g/100 mL | 2019 | |
| 
 Indications
 | |||||
| Natures Formulae Health Products Ltd. | Ointment | Topical | 12.7 mg/1 g | 2016 | |
| 
 Indications
 | |||||
| Saje Natural Business Inc. | Ointment | Topical | 12.7 mg/1 g | 2016 | |
| 
 Indications
 | |||||
| TriVita, Inc. | Gel | Topical | 8.5 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2022 | |
| 
 Indications
 | |||||
| TRUVITALITY, LLC | Gel | Topical | 4 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Two Old Goats | Lotion | Topical | 1.35 mg/100 mL | 2019 | |
| 
 Indications
 | |||||
| BNG Enterprises DBA Herbal Clean | Gel | Topical | 4.56 g/114 g | 2018 | |
| 
 Indications
 | |||||
| TELEBRANDS CORP | Lotion | Topical | 8 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Pharmaneek, Inc. | Patch | Topical | 200 mg | 2019 | |
| 
 Indications
 | |||||
| Unishield | Lozenge | Oral | 7.6 mg | 2021 | |
| 
 Indications
 | |||||
| Universal Distribution Center LLC | Gel | Topical | 1.25 g/100 g | 2020 | |
| 
 Indications
 | |||||
| Universal Distribution Center LLC | Gel | Topical | 1.25 g/100 mL | 2020 | |
| 
 Indications
 | |||||
| TARGET CORP | Patch | Topical | 50 mg | 2021 | |
| 
 | |||||
| Rejuvica LLC | Cream | Topical | 45 mg/1 mL | 2019 | |
| 
 Indications
 | |||||
| McCure Health Solutions Inc. | Gel | Topical | 25 mg/1 g | 2015 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Tablet | Topical | 0.45 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Tablet | Topical | 0.45 mg | 2025 | |
| 
 Indications
 | |||||
| Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Tablet | Topical | 0.45 mg | 2025 | |
| 
 Indications
 | |||||
| The Procter & Gamble Manufacturing Company | Lozenge | Oral | 5.8 mg | 2025 | |
| 
 Indications
 | |||||
| Beijing HKKY Medical Tech. Co. , Ltd. | Aerosol, Spray | Topical | 0.01 g/1 g | 2023 | |
| 
 Indications
 | |||||
| I Shay Cosmetics Inc | Cream | Topical | 1.25 g/100 g | 2021 | |
| 
 Indications
 | |||||
| Walgreen Company | Liquid | Topical | 160 mg/1 mL | 2014 | |
| 
 Indications
 | |||||
| Walgreen Company | Gel | Topical | 2.5 g/100 g | 2014 | |
| 
 | |||||
| WALGREEN CO. | Gel | Topical | 0.1 g/100 g | 2012 | |
| 
 Indications
 | |||||
| Walgreens | Lozenge | Oral | 5.8 mg | 2025 | |
| 
 Indications
 | |||||
| Walgreens, Co | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Walgreens, Co | Gel | Topical | 40 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| Walgreens Company | Patch | Topical | 5 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Walgreens | Aerosol, Spray | Topical | 16 g/100 g | 2023 | |
| 
 Indications
 | |||||
| Walgreens | Lozenge | Oral | 7.5 mg | 2025 | |
| 
 Indications
 | |||||
| Walgreens Company | Gel | Topical | 2 g/100 g | 2022 | |
| 
 Indications
 | |||||
| Walgreen Company | Gel | Topical | 20 mg/1 g | 2015 | |
| 
 Indications
 | |||||
| Davion, Inc | Powder | Topical | 1 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Walgreens | Lozenge | Oral | 5.4 mg | 2025 | |
| 
 Indications
 | |||||
| Walgreens | Lozenge | Oral | 20 mg | 2025 | |
| 
 Indications
 | |||||
| Walgreens | Lozenge | Oral | 20 mg | 2024 | |
| 
 Indications
 | |||||
| WALGREEN COMPANY | Gel | Topical | 5 mg/1 g | 2017 | |
| 
 Indications
 | |||||
| CA-BOTANA INTERNATIONAL | Gel | Topical | 6 g/120 g | 2016 | |
| 
 | |||||
| The Mentholatum Company | Patch | Topical | 50 mg | 2017 | |
| 
 Indications
 | |||||
| I Woke Up Well Distributing Inc | Cream | Topical | 0.03 g/1 g | 2018 | |
| 
 Indications
 | |||||
| WINCO FOODS, LLC | Patch | Topical | 50 mg | 2020 | |
| 
 | |||||
| LJ Pharma | Gel | Topical | 2 g/100 g | 2025 | |
| 
 Indications
 | |||||
| Foshan Chancheng District Baiyikun Trading Firm | Patch | Topical | 0.14 g | 2024 | |
| 
 | |||||
| Dynarex Corporation | Gel | Topical | 4 g/100 mL | 2018 | |
| 
 Indications
 | |||||
| Omom Pharmaceuticals, Inc. | Gel | Topical | 1.25 g/100 g | 2017 | |
| 
 Indications
 | |||||
| Cintas Corporation | Lozenge | Oral | 7 mg | 2023 | |
| 
 Indications
 | |||||
| Cintas Corporation | Lozenge | Oral | 9 mg | 2023 | |
| 
 Indications
 | |||||
| Cintas Corporation | Gel | Topical | 100 mg/1 g | 2024 | |
| 
 Indications
 | |||||
| Cintas Corporation | Spray | Topical | 100 mg/1 mL | 2025 | |
| 
 Indications
 | |||||
| China Ningbo Shangge Cosmetic Technology Corp | Gel | Topical | 3 g/227 g | 2014 | |
| 
 | |||||
| Rejoice International | Gel | Topical | 3 g/227 g | 2014 | |
| 
 | |||||
| MAXAM | Patch | Topical | 4 g/100 g | 2018 | |
| 
 Indications
 | |||||
| Guangzhou ChuanMa International Trading Co. , Ltd. | Cream | Topical | 1 g/100 g | 2025 | |
| 
 | |||||
| Guangzhou ChuanMa International Trading Co. , Ltd. | Cream | Topical | 1 g/100 g | 2025 | |
| 
 | |||||
| Wuhan Chinese Moxibustion Technology Development Co. ; Ltd. | Patch | Topical | 10 mg/1000 mg | 2003 | |
| 
 | |||||
| GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD | Plaster | Transdermal | 35 mg | 2022 | |
| 
 Indications
 | |||||
| GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD | Plaster | Transdermal | 35 mg | 2022 | |
| 
 Indications
 | |||||
| KOBAYASHI Healthcare International, Inc. | Spray | Topical | 160 mg/1 g | 2018 | |
| 
 Indications
 | |||||
| KOBAYASHI Healthcare International, Inc. | Gel | Topical | 70 mg/1 g | 2018 | |
| 
 Indications
 | |||||
| KOBAYASHI Healthcare International, Inc. | Liquid | Topical | 160 mg/1 mL | 2018 | |
| 
 Indications
 | |||||
| KOBAYASHI Healthcare International, Inc. | Gel | Topical | 70 mg/1 g | 2018 | |
| 
 Indications
 | |||||
Repacked & Relabeled Product Labels
The table below lists products marketed under repackaged or relabeled National Drug Codes (NDCs).
Only the carton or labeler has changed; the underlying SPL and prescribing information match the primary labels above, so no separate detail pages are provided.
Below are the non-prescription pack sizes of Equate Honey Lemon Cough Drops (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
| Label | Forms | Routes | Menthol | FDA year | 
|---|---|---|---|---|
| A-S Medication Solutions | Gel | Topical | 40 mg/1 mL | 2012 | 
| A-S Medication Solutions | Gel | Topical | 50 mg/1 mL | 2016 | 
| NuCare Pharmaceuticals, Inc. | Gel | Topical | 50 mg/1 mL | 2016 | 
| A-S Medication Solutions | Gel | Topical | 50 mg/1 mL | 2016 | 
| A-S Medication Solutions | Gel | Topical | 40 mg/1 mL | 2013 | 
| DenTek Oral Care, Inc. | Patch, Extended Release | Transmucosal | 2.5 mg/194.85 mg | 2015 | 
| Rebel Distributors Corp | Gel | Topical | 0.16 g/1 g | 1997 | 
| Navajo Manufacturing Company Inc. | Powder | Topical | 0.15 g/100 g | 2021 | 
| SAS Group Inc. | Cream | Topical | 5 1/85 g | 2010 | 
| A-S Medication Solutions | Lozenge | Oral | 5.8 mg | 2013 |